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Spinal cord injury is debilitating and patients have historically had little 
hope for functional recovery. Astrocytes forming the scar tissue and producing 
chondroitin sulfate proteoglycan (CSPG) were often identified as the chief culprits 
for inhibiting neuronal regeneration. However, as the complex role of astrocytes 
in spinal cord injury are increasingly understood, the benefits they provide for 
healing have become valuable tools towards promoting recovery. Inducing 
aligned astrocyte populations in the wound site may promote functional recovery 
outcomes. Many approaches have been researched for restoring signaling after 
spinal cord injury, but artificial nerve guidance devices are particularly interesting 
as they can provide lasting directional cues to the injury site. 
The goal of this research was to demonstrate and measure the impact of 
surface protein patterns on astrocyte reactivity in an effort to reduce their neuron-
inhibitory CSPG production. By quantifying CSPG expression as measure of 
astrocyte reactivity, no change in reactivity was seen with varying amounts of 
fibrinogen surface coverage. However, astrocytes were found to selectively 
remove adsorbed fibrinogen from glass surfaces from amongst other proteins 
and also secrete CSPG onto surfaces. To mitigate protein pattern removal, a 
cross-linked patterning method based on microcontact printing was developed to 
attach protein patterns to collagen gels. Protein patterns were first created on 
 glass and transferred to collagen by gelling collagen directly on top of the pattern. 
This construct was then peeled off from glass to create free standing collagen 
sheets with one patterned surface. Stripe patterns of various extracellular matrix 
molecules were thus patterned and found to align astrocytes on collagen gel 
surfaces and reduced astrocyte CSPG expression. To understand how 
astrocytes interact with surface patterns, astrocyte morphology was measured in 
real time. This revealed that astrocytes prefer adhesion to laminin over aggrecan 
and will shift their cell bodies accordingly. Astrocytes initially extend multiple 
processes upon attachment and span the largest distances when presented with 
mixed adhesion cues, up to 150 micrometers. Collectively, this research 
demonstrates the importance of surface protein patterns in biasing astrocyte 
behavior and provides a new technique for further modifications of collagen 
hydrogels for use as nerve guidance materials. 
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1.1. Spinal Cord Injury and Inflammation 
The mammalian central nervous system (CNS) is largely ineffective at 
repairing or regenerating functional tissue after injury. Due to the role of the CNS 
in signaling and sensing, this loss of motor and sensory function leads to 
dramatic detriment to the quality of life of affected individuals. Spinal cord injury 
(SCI) is particularly impactful as individuals may require lifelong medical aids to 
compensate for the loss of control of basic physiologic functions, including 
respiration, bladder and bowel function, and ambulation. According to the 
National SCI Statistical Center, an estimated 12,500 SCIs occur each year and 
276,000 people are living with SCI in the United States.  Vehicular accidents and 
falls account for 68% of all SCI, with violent acts and sports collisions accounting 
for another 23% of cases.  Males account for 79% of SCI patients. The average 
patient will incur treatment costs ranging from $300,000 to $1,000,000 for the first 
year of treatment and $40,000‒$180,000 per subsequent year depending on 
injury severity. Around 30% of SCI patients must be rehospitalized in a given 
year. Ultimately, life expectancies for SCI patients are dramatically reduced, with 
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complications from pneumonia and septicemia being the most common[1]. To 
date, no treatment has proven completely successful in restoring full spinal cord 
functionality after SCI[2]. 
Poor regenerative ability was once thought to be intrinsic to CNS neurons 
themselves, but even adult neurons retain some regenerative ability, albeit less 
than younger cells[3,4]. The unique cellular responses that occur in the CNS 
wound environment contribute to the lack of neuronal repair. The process of 
wound healing in the mammalian CNS has several well-documented stages. 
Initial injury is similar to that of other tissues with the first processes being tissue 
trauma, ischemia, blood vessel compromise, and local hemorrhage. This is the 
acute phase of the injury. The CNS is normally immune privileged and separated 
from general blood exposure with the blood‒brain barrier (BBB) or analogous 
blood‒spine barrier (BSB). Once damage has occurred, the infiltration of blood 
molecules and cells triggers cascades of behavioral changes in each of the major 
cell types in the CNS. Figure 1.1 summarizes the timing of these wound healing 
events after SCI occurs, which are separated into three periods: acute (seconds 
to minutes after SCI), secondary or sub-acute (minutes to weeks after SCI), and 
chronic (lasting from months to years after SCI)[5]. 
Neurons that are severed form a retractive endball proximal to the injury 
and severed distal portions of axons degenerate. Furthermore, neurons 
associated with the wound undergo apoptosis and Wallerian degeneration[6,7]. 
Without axons making synaptic connections, signaling ceases, which leads to the 
primary symptoms of SCI. Neuronal death continues after hemostasis has been 
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established as macrophages begin the work of clearing cellular debris. This 
signals the beginning of the secondary or sub-acute response. It is during this 
secondary phase that the most damage is done to CNS tissue and macrophages 
mediate much of this secondary injury[8]. These phagocytotic cells have been 
shown to come from two sources: derived from monocytes in circulating blood 
and from a resident population in CNS tissue, known as microglia[9]. Microglia 
become activated immediately along with neutrophils from leaked blood. 
Monocytes are then recruited to the site.  Both of these cell groups begin 
producing cytokines, proteases, free radicals, and neurotoxic enzymes[5,10]. 
Microglia and macrophages are also capable of neuroprotective behavior 
in addition to neurotoxicity. Therefore, the complexity of macrophage reactivity is 
difficult to compartmentalize. A single stimulus, zymosan or lipopolysaccharide 
(LPS), injected into the spinal cord can cause macrophages to simultaneously 
damage and protect neurons[11]. To distinguish between macrophage actions, 
there have been efforts to characterize cell populations. Macrophages have been 
historically categorized into M1 and M2 groups of activation for classic and 
alternative pathways, respectively. Some have suggested further divisions to 
further clarify the spectrum of macrophage behavior[12–14], but research on the 
impact of macrophages on the CNS has largely relied on M1/M2 
characterizations. In general, M1 activated macrophages present a more 
proinflammatory phenotype and inhibit cell proliferation typified by nitrous oxide 
(NO) production; M2 macrophages are thought to promote tissue repair via 
ornithine expression[15]. These roles have also been distinguished in the 
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recovering CNS[16]. Additionally, M2-macrophage-conditioned media had a 
demonstrated influence on promoting neurons to overcome growth barriers[17]. 
M1 microglia and macrophages tend to dominate the secondary phase of SCI 
healing[18]. By inducing a greater amount of M2 activated microglia, more nerve 
tracts were preserved after SCI[19]. 
The origin of the macrophages also plays a role in their response to SCI. 
Macrophages entering the region from blood have been identified as instigators 
of the inflammatory injury to neurons[20]. Another detrimental effect of non-
resident macrophages is their promotion of fibrous scar formation[21]. However, 
there is also evidence that blood-origin macrophages and their secretion of 
interleukin-10 in the wound site is helpful in reducing inflammation and promoting 
some motor recovery[22]. One potential factor for the multiple roles of monocyte-
derived macrophages is the timing at which they enter the injury site as they 
respond to differing signals from resident cells[23]. Migrating M2 macrophages 
were shown to enter the wound milieu through cerebrospinal fluid (CSF) and 
blocking their ability to enter led to impaired motor recovery[24]. As reviewed by 
Oyinbo, secondary injury has numerous mechanisms for damaging CNS cells, 
including the triggering of apoptosis, ionic imbalance, neurotransmitter excess, 
and free radical and reactive oxide production[25]. Likewise, the onset of 
secondary injury is most likely the earliest period where interventions may be 
clinically staged. In humans, initial activation of microglia occurs 1‒3 days after 
injury as evidenced by acquisition of amoeboid phenotypes and coincides with 
monocyte infiltration. Evidence of elevated macrophage levels via CD68 staining 
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persists from weeks to months post-injury[26]. Microglia from adult human cortex 
were compared to those in mice and were found to have very similar 
morphological characteristics, suggesting that these may be well conserved 
across species[27]. Once the chronic stage of the injury response is reached, 
macrophage activity is reduced and neurons begin to resprout axons[5]. 
The myelin sheathing cells of the CNS, oligodendrocytes, are also 
susceptible to secondary damage and have been observed to undergo apoptosis 
after SCI; their remnants are largely phagocytosed by macrophages[28]. This 
loss of oligodendrocytes is concomitant with neuronal death[29] and has a 
detrimental effect on the ability of neurons to transmit action potentials. 
Oligodendrocyte precursors residing in the CNS have the ability to remyelinate 
neurons, but this activity is inhibited by a class of molecules known as 
chondroitin sulfate proteoglycans (CSPGs) produced after injury[30,31]. 
Neurotrophin-3 (NT-3) and brain-derived neurotrophic factor (BDNF) were both 
found to promote oligodendrocyte remyelination after SCI[32]. M2 macrophages 
have also been shown to promote oligodendrocyte differentiation and 
remyelination[33]. 
 
1.2. Astrocytes and the Glial Scar 
The most abundant cells in the CNS, astrocytes, undergo a process 
known as astrogliosis or reactive gliosis where cells begin profound 
morphological and physiological changes after injury[34]. In the prechronic 
phases of SCI response, astrocytes begin to reestablish the BSB and are able to 
6 
 
reduce the extravasation of larger blood products although some leakage of 
smaller molecules remains up to 4 weeks later[5]. Astrocytes do not proliferate 
immediately after injury, but do so rapidly after the acute phase of injury has 
passed. This proliferation only persists for around 1 week, after which the 
expression of cell-cycle markers is limited[35]. Many resident astrocytes also die 
as a result of the inflammatory environment produced by macrophages[8,36], 
although human astrocytes do not demonstrate caspase-3-mediated apoptosis 
after SCI[28]. The loss of tissue leads to the formation of a necrotic cavity, which 
is then either encircled or infiltrated by reactive astrocytes[8,37]. These reactive 
astrocytes persist into the chronic phases of healing, and eventually these 
hypertrophied, reactive astrocytes are the dominant cell type present in the 
wound site[36]. In humans, reactive astrogliosis exhibits only slight glial fibrillary 
acidic protein (GFAP) upregulation, which peaks around 4 months after injury 
and is reduced to baseline levels after 1 year[26]. 
The stable meshwork of reactive astrocyte tissue is known as the glial 
scar[38,39]. The disorganized glial scar stands in stark contrast to the well-
organized and aligned astrocytes found in intact spinal cord tissue. It has been 
shown that neurons follow these longitudinal astrocyte processes in healthy 
spinal cord[40]. It is thought that the random, disorganized state of astrocytes in 
the glial scar is a contributing culprit to failed neuronal regeneration, as neurons 
are known to be sensitive to topographical cues[41]. The extent of the scar has 
been historically identified via GFAP, an intermediate filament of the cytoskeleton, 
and vimentin expressed in reactive astrocytes[34,42]. The glial scar has been 
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found to delimit the extent of axonal processes around injury sites and this 
inhibition has been attributed to both its lack of physical, directional support as 
well as upregulation of CSPGs[43]. Chondroitin sulfate (CS) proteoglycans are 
composed of a core protein molecule with CS sugar chains attached. CSPGs are 
another hallmark of astrocyte reactivity and astrocytes have been shown to 
express multiple types of CSPGs after SCI, including neurocan, phosphacan, 
brevican, versican, and aggrecan[44–48]. While macrophages, oligodendrocytes, 
and oligodendrocyte precursors also produce some CSPG in the SCI wound 
site[48,49], astrocytes are the key producers of these molecules. 
The CSPGs expressed by astrocytes have been viewed as the chief 
components of the extracellular matrix (ECM) responsible for neuron inhibition in 
the glial scar[50]. The functions of CSPGs, however, are not always inhibitory 
and are still being explored[51,52]. Astrocyte CSPG production has been shown 
to be triggered by transforming growth factor β (TGF-β) available from blood 
fibrinogen (FBG). As the BBB is compromised after injury, the influx of FBG 
initiates the creation of this neuron inhibitory ECM[53]. An additional function of 
CSPG expressed by astrocytes in the glial scar may be influencing macrophage 
activation[54]. By inhibiting CSPG synthesis with a xyloside immediately after 
injury, macrophage cytokine expression favored necrosis and led to more tissue 
loss. Conversely, by applying xyloside 2 days after injury to inhibit CSPG 
production after the initial burst led to improved neuronal recovery[54]. 
It is clear astrocytes are a very heterogeneous population, and, like 
macrophages in the inflammatory response, it is overly simplistic to characterize 
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astrocyte reactivity solely as positive or negative for wound healing[55–57]. 
Astrocytes have been found to exhibit differing forms of reactivity in response to 
different triggers[35], thus astrocytes are capable of a spectrum of behaviors 
during astrogliosis. 
The mere presence of astrocytes in the scar does not cause the failure of 
neurons to regenerate. In fact, reactive astrocytes have been shown to be vital in 
protecting CNS tissues from further damage after injury[58]. This protective 
nature of astrocytes is due to their ability to secrete neurotrophic factors as well 
as their ability to balance other signaling molecules[59]. For example, astrocytes 
scavenge excess glutamate and prevent excitotoxicity[60,61]. It has been shown 
that in the brain, newly differentiated astrocytes migrate to wound sites to 
perform neuroprotective functions after injury from the subventricular zone in the 
brain[62]. Thus, the relationships between astrocytes and the wound 
environment are still not fully understood. Since astrocytes do play beneficial 
roles, the effort to reduce inhibitory effects while maintaining the positive 
influence of astrocytes is a promising approach to improving SCI repair. 
 
1.3. SCI Treatments 
There are multiple approaches to treating SCI. The injection of 
methylprednisolone soon after acute injury to combat some of the impact of 
secondary inflammation has been approved by the Food and Drug Administration 
(FDA), but the efficacy of this treatment has been criticized[63,64]. To improve 
outcomes, there are currently 668 clinical trials in the United States aimed at 
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improving SCI recovery (clinicaltrials.gov, December 2014). The goals for 
supporting regeneration and repair after SCI include protecting remaining 
neurons, decreasing inhibition in the injury ECM, increasing permissive signals to 
augment growth, providing physical support, and reinforcing cell 
populations[2,65]. Growth-promoting biomaterials, stem cell transplants, tissue 
engineered constructs, tissue grafts, pharmaceutical agents, and drug-delivery 
devices may all potentially improve SCI recovery. In the present work, I focus on 
the application of prefabricated biomaterials. The benefits of this approach 
include better control over material properties, increased potential for off-the-
shelf availability, and reduction in processing time compared with more complex 
and cell-based systems. However, artificial biomaterials lack the signals and 
structures found in either natural tissue or with native cells as well as the 
continued, dynamic support that can occur with living tissues. Ideally, the 
utilization of such materials could be combined with other available techniques in 
the future, as the largest likelihood for success comes from combinatorial 
tactics[66]. While regrown nerve tracts are not always necessary for improved 
function[67], evidence indicates that directional neuronal growth that spans the 
injury can contribute positively to functional recovery[68–70]. 
Pharmaceutical applications have been promising. As CSPG was 
identified as the chief inhibitory culprit in the glial scar, the use of chondroitinase 
ABC (ChABC), an enzyme that digests the CS side chains off of the protein 
cores in CSPGs, has been used extensively[71,72]. Rats that had ChABC 
administered after spinal cord hemisection above the diaphragm  were able to 
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recover respiratory function[73]. The application of this enzyme presents 
challenges as well. The optimal delivery method, timing, and stability will need to 
be resolved. Thermal stability of ChABC is also a challenge for sustained 
activity[74,75]. Likewise, the core proteins of proteoglycans left behind after 
ChABC digestion have also been shown to contribute to neuronal 
inhibition[44,76]. The alternative approach for mitigating CSPG inhibition has 
been to interfere with neuronal receptors for CSPG, including Nogo receptors[77] 
and protein tyrosine phosphatase (PTPσ)[78]. Recently, a PTPσ‒mimetic peptide 
was developed and shown to improve neuronal recovery with systemic 
delivery[79]. 
Cell therapies have also been appealing as cells can provide appropriate 
growth factors, binding molecules, and physical guidance cues necessary for 
neurons to allow directional regrowth. Many cell types have been pursued, 
including nerve grafts, stem cells, Schwann cells, and precursors[2,65]. However, 
application of stem cells carries inherent ethical concerns regarding cell sourcing 
and the potential for tumorigenesis[80,81]. Interestingly, one potential reason 
progenitor and precursor cells are effective is actually an induced increase in 
astrocyte activity[82]. Recent progress in a human patient has been reported 
where olfactory ensheathing cells were implanted into a spinal cord transection. 
The implantation surgery removed the resident glial scar and also added 
autologous nerve grafts in conjunction with the olfactory cells. After 19 months, 
evaluation showed improvement in muscle mass, stability, and partial recovery of 
sensation and voluntary movement below the injury[83]. 
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Of particular note, astrocytes have also been an attractive cell population 
to treat SCI due to their positive effects towards tissue repair. An early 
experiment demonstrated that applying embryonic astrocytes on cellulose 
supports aided dorsal root axon growth back into astrocyte grey matter[84]. 
Neonatal astrocytes seeded within collagen gels also increased neuronal fibers 
that were associated with the transplanted cells. This led to modest 
improvements in locomotion[85]. Astrocytes differentiated with BDNF from 
precursors were found to be beneficial to functional recovery after SCI in adult 
rats. These cells were seeded in collagen gels without any particular directional 
bias. Their presence led to a net positive increase in neuronal outgrowth. While 
likely still producing CSPG and other potentially inhibitory molecules, their 
supportive aspects allowed for 60% of severed axons to regrow[68]. These 
results have also been supported using astrocytes derived from human precursor 
cells[86,87]. Differentiated human astrocytes without any scaffold have also been 
used, but showed no increased motor recovery after injection into spinal cord 
contusion. There was, however, some improvement in sensory function and 
reduction in scar formation as the cells migrated and proliferated to fill in the 
wound cavity[88]. A key feature as to the success of younger or differentiated 
astrocytes could be in a decrease in their inhibitory nature. The injection of 
differentiated astrocytes in medium into a contusion wound in the spinal cord led 
to a reduced amount of GFAP and CSPG expression[89]. Another potential 
benefit of using young cells is their plasticity and ability to reverse 
phenotypes[87]. As Chu et al. reviewed, astrocyte transplantation is a 
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multifaceted problem and details regarding cell population and transplantation 
timing must be considered to understand the efficacy of astrocytes as a 
therapeutic treatment[90]. 
Cell therapy has also been coupled with implantable devices with 
directional channels to provide trophic and physical support for nerve 
repair[91,92]. Another enticing alternative implantable device is microelectrodes. 
Recent work with the use of implanted electrodes for epidural stimulation has 
allowed four human males to control voluntary motor functions in the lower 
extremities distal to the injury site. As this approach has demonstrated, there 
may be spared nerve tracts after SCI even with complete loss of motor and 
sensory functions[93]. 
 
1.4. Nerve Guidance Device Design 
Inspired by the success of artificial guidance devices in aiding neuronal 
regeneration in peripheral nervous system (PNS) injuries, nerve guidance 
devices have been tested to repair SCIs. Most human SCIs are of a contusion 
nature, meaning some spinal cord tissue is potentially undamaged as opposed to 
damage to all nerve tracts in a complete transection. Thus, the application of 
nerve guidance devices may be an overly invasive clinical procedure depending 
on the severity of injury. Any device interventions used to improve neuronal 
regeneration will also unavoidably cause surgery-associated damage to CNS 
tissues. A subsequent concern after intervention is then the mediation of the 
CNS inflammatory response triggered by the insertion and the presence of these 
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foreign bodies. However, the application of such devices provides a unique 
potential benefit as currently no pharmaceutical or injectable material can provide 
cellular-level directional information during the healing process. They also serve 
as valuable tools for researching the behavioral mechanisms of CNS cells to 
injury and correlating tissue regrowth to functional outcomes. 
In addition to restarting the CNS injury cascade, an additional complication 
for an implanted support device arises from the fact that device surfaces will be 
adsorbed with fibrinogen after blood contact. As previously mentioned, this blood 
molecule initiates CSPG production cascades in astrocytes. It remains unclear, 
however, whether astrocytes respond to FBG after it has physically adsorbed to 
a surface with its associated conformational changes. Similarly, the presence of 
FBG at the device-astrocyte interface may cause astrocytes to increase CSPG 
expression. In Chapter 2, I investigated the astrocyte CSPG response to FBG 
adsorbed to glass surfaces to gain insight on these quandaries. If FBG presence 
causes devices to be increasingly neuron inhibitory, perhaps precoating devices 
with alternative proteins or designing materials to minimize FBG adsorption 
would improve neuronal regeneration on the device. My hypothesis was that 
astrocytes would still recognize FBG even after adsorption and that increasing 
the amount of FBG exposure would lead to a coinciding increase in CSPG 
expressed on astrocyte surfaces as indicated by immunocytochemistry. The CS-
56 antibody has been correlated with inhibition of neuronal outgrowth and is a 
core contributor of the poor recovery seen in SCI[43]. 
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The working basis of grafts and nerve guidance conduit (NGC) devices is 
to provide a substrate for regenerating nerves to grow upon and thereby facilitate 
the reconnection of severed nerve tracts. NGCs can also isolate the recovering 
nerve tissue from foreign cells and cytokines[94]. Application of such devices in 
SCI models have shown that CNS neurons can regenerate through given 
constructs like their PNS counterparts[95]. As mentioned earlier, timing is an 
important factor for glial scar maturation. NGC‒based treatment will likely target 
individuals in the chronic phases of recovery with developed glial scars, a niche 
that is not well served with acute treatment methods. There has been prolific 
improvement on these guidance devices from basic tube shapes to those 
containing grooves, multiple lumens, or nanofibers. These NGCs also have been 
supplemented with the addition of ECM proteins (laminin [LN], fibronectin [FN], 
collagen)[96], growth factors (e.g. glial cell-derived neurotrophic factor [GDNF], 
nerve growth factor [NGF])[95], and the aforementioned cell-seeding. Cell 
treatments are particularly potent as the cell populations provide physical support 
as well as both soluble and insoluble signals to regenerating neurons. Stem cells 
(mesenchymal stem cell [MSC], glial-restriced precursor [GRP]), as well as 
support cells (Schwann Cells, astrocytes) have all been shown to improve 
regeneration compared with scaffold materials alone[86,97–99]. 
There are several key factors to consider while designing a CNS NGC 
which have been well reviewed. These include mechanical strength, porosity, 
degradation, electrical conductivity, cell interaction, growth factors, and 
directional cues[66,94].  As summarized in Figure 1.2, many of these design 
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parameters function to increase neuronal viability as well as provide directional 
cues.  
Bioresorpable and biodegradable materials are often considered the most 
viable materials for NGCs as persistent devices can lead to continued cellular 
response and compression syndromes[100]. Popular biodegradable material 
choices besides collagen include the poly(α-hydroxyacids) family of polymers, 
which comprises poly(glycolic acid) (PGA), poly(lactic acid) (PLA), poly(lactic 
acid-co-glycolic acid) (PLGA), and poly(lactide-co-caprolactone) (PCL), as well 
as chitosan and poly(β-hydroxybutyrate)[66]. Collagen is expressed after SCI in 
forms I, III, and IV. While collagen may form a barrier to regrowth[101], there is 
evidence that collagen itself does not contribute to axonal inhibition during SCI 
recovery[102–105]. Fibroblasts from surrounding tissues likely contribute some of 
this collagen, but astrocytes themselves can produce it in many of its various 
types[105–107]. As a regenerative biomaterial for SCI, functional recovery and 
neuronal outgrowth have been shown through collagen biomaterials in in vivo 
SCI models[67,108–110]. 
There have been multiple approaches to improve bioactivity and neuronal 
guidance with collagen-based NGCs. Application of collagen by gelling in-situ 
provides more robust neuronal growth through collagen[111]. The physical 
alignment of collagen into nanofibers also promotes directional neuronal 
outgrowth[112]. The chemical addition of brain-derived neurotrophic factor 
(BDNF) and antagonists to epidermal growth factor receptor (EGFR) to oriented 
collagen fibers restored synaptic connections in rats across a 6 mm spinal cord 
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transection[113]. Another example of a synergistic approach to adding additional 
bioactivity to collagen was the addition of neurotrophin-3 and ChABC to collagen 
nanofibers. These devices provided topographical cues, reduced inhibition, and 
added growth signals all in one and were shown to sustain dorsal root ganglion 
(DRG) outgrowth in vitro[72]. Even when co-gelled with potentially inhibitory 
chondroitin-6-sulfate, collagen still supported spinal cord neuron penetration[114]. 
Collagen has been a popular material for numerous applications for neural 
guidance devices as it has demonstrated biocompatibility and the ability for local 
cells to remodel and degrade the material[91,115,116]. Collagen has also been 
extensively tested to allow for control over physical properties, including porosity 
and stiffness [117,118]. With such extensive research history and documented 
results, I chose collagen as a model biomaterial for my studies in Chapter 3. 
 
1.5. Influence of Surface Cues 
The surface of an NGC is an important factor for determining how the 
device interfaces with the body. As expected, macrophages are active at the 
surface of CNS implants. Macrophages have been shown to encapsulate 
conduits made from genipin-linked gelatin by 8 weeks post-implantation[119], 
thus giving another impetus for biodegradable materials to reduce chronic 
inflammatory responses. Similarly, macrophages and multinucleated cells have 
been found to surround and infiltrate fibrillar PLGA/PCL implants[120]. 
Macrophages were found to infiltrate and surround 
poly(hydroxyethylmethacrylate) (pHEMA) scaffolds 1 week after implantations, 
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though their presence was markedly decreased after 4 weeks. This 
corresponded with a similar trend for CSPG expression around the implant even 
while astrocyte GFAP levels remained relatively constant[121]. Because of this, 
any surface patterns or cues must resist modification or removal from the surface 
in order to have prolonged efficacy past the initial inflammatory response. 
 Importantly, neurons are highly sensitive to surface cues. In a study of 
DRG on collagen type I, DRG enclosed between glass with a directional pattern 
and the gel preferentially followed the surface pattern. It was also shown that the 
majority of neurons grew on the surface of the gel rather than penetrate into 
it[122]. The use of grooved surfaces has been shown to guide neurite extension, 
as neurites will follow the grooves in a parallel fashion if the grooves have 
sufficiently large features (around 0.2 µm)[41,123] . Similarly, incorporation of 
fibers on the surface has shown potent guidance of neuron outgrowth[41]. Finally, 
ECM protein stripes have been shown to align and direct neurons[124]. 
Glia are also impacted by surface properties. Oriented PCL fibers have 
been shown to direct oligodendrocyte migration along surfaces[125]. Astrocytes 
also align on surfaces with grooved topography[126]. Astrocytes and microglia 
decrease both rates of proliferation and migration when confronted with 4.7 µm 
pillars on PDMS but are not impacted by pillars that are 0.5 µm tall[127]. 
Interestingly, fibers have also been shown to guide astrocytes and increase their 
rate of migration onto NGCs. Hurtado et al. formed sheets with PLA fibers that 
were rolled up to produce an NGC that had surface topography to aid neurons in 
bridging a SCI. The authors observed improved function and neuronal outgrowth 
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that was correlated with increased astrocyte migration onto the device. From this 
observation, the authors suggest that neurons present pioneering growth cones 
after which astrocytes follow in their supportive role. While not necessarily causal, 
this in vivo finding demonstrates that astrocytes will interact with the NGC 
surface and that functional recovery occurs with their presence[128]. 
As regenerating neurons will extend growth cones to sample the 
environment, it will be beneficial to combine multiple cues to promote correct 
directional growth. This type of synergy has recently been demonstrated where 
the application of electrical stimulation on DRG neurons grown on aligned PLA 
fibers led to an increase in outgrowth compared to either the electrical or 
topographical stimulus alone[129]. Astrocytes are an ideal candidate for the role 
of neuron guide as they provide both physical and molecular surface cues for 
alignment. As astrocytes are the dominant cell type at chronic healing phases, 
the ability to establish a supportive, directive tissue in place of the glial scar could 
provide long-lasting information to regenerating neurons. 
While surface topography has been readily applied to NGC research, 
aligned surface protein patterns have only begun to be explored as novel printing 
techniques are developed. Such protein patterns printed onto glass surfaces 
have been shown to align astrocytes in vitro[130,131]. Surface-based cues are 
particularly appealing as they can be added to existing biomaterial platforms and 
can eventually utilize complex patterning techniques. One particular challenge 
presented by using soft materials is that deformation makes microcontact printing 
difficult[132]. To investigate whether surface patterns that have been effective at 
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aligning astrocytes on glass remain so when presented on a NGC material, I 
developed a technique to place directional protein patterns onto the surface of 
collagen type I in Chapter 3. I hypothesized that utilizing a bifunctional crosslinker, 
I could physically attach ECM protein patterns first created on glass to collagen 
as it was gelled on top of the patterns. I anticipated that the spatial placement of 
molecules would impart similar effects on aligning astrocytes as seen on 
patterned glass. 
Fibers often rely on the addition of ECM components to improve cell 
affinity and increase their efficacy[133]. This equates to aligned ECM molecules 
in conjunction with topography. My present work allows direct placement of ECM 
components in aligned patterns and, while lacking topography, creates 
opportunities for placement of multiple molecules in controlled amounts and 
variations in patterns. There have been several techniques for patterning 
surfaces of soft substrates with protein patterns. These include 
polydimethylsiloxane (PDMS), polyvinyl alcohol, and polyacrylamide[132,134–
136]. Recent work has also demonstrated controlled patterning onto PCL 
fibers[137]. Utilizing freeze-drying, Matrigel® and gelatin can also be directly 
printed with proteins[138]. Several of these techniques would be amenable to 







1.6. Positive Effects of Astrocyte Alignment 
In addition to the myriad positive impacts of astrocytes described above, 
aligned astrocytes have also demonstrated the ability to guide subsequent 
neuronal growth beyond simple topographical contact guidance. Clearly, the 
presence of astrocytes with their thicker nuclear regions and extended processes 
provide topographical information to neurons. This effect has been successfully 
repeated on materials that mimic astrocyte topography by casting upon cell 
layers. Cell-inspired computer-aided design (CAD) patterns also provided 
neurons with topography-mediated guidance[139]. However, these physical cues 
are also accompanied by numerous chemical signals expressed by astrocytes, 
including laminin (LN), fibronectin (FN), neural cell adhesion molecule (NCAM), 
and N-Cadherin[140]. In healthy spinal cord tissue, astrocytes, which are aligned 
and organized, are potent directors of neuron outgrowth and are co-localized with 
directed nerve tracts[141,142]. Laminin has been commonly used for guidance 
studies and is expressed by astrocytes[143]. Fibronectin has also been shown to 
be important for aiding transitional binding to LN [144]. FN is also important for 
astrocyte-mediated guidance of regenerating neurons and is found to be 
colocalized with axons[130,145]. Astrocytes have been aligned in vitro using 
electric fields[146], topography[126], protein patterns[130], and mechanical 
force[147]. Intuitively, because astrocytes are pivotal to maintaining healthy 
cellular environments for neurons, their presence on NGCs could potentially 
benefit neuronal response.  
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It has been shown that aligned astrocytes cause neurons to follow their 
growth directions and also to extend longer outgrowth[126,130,147]. Even in a 
reactive state as evidenced by positive GFAP and CSPG staining, aligned 
astrocytes permit and direct robust neuron outgrowth in vitro. This behavior 
continues even after astrocytes have been fixed, signifying that cell-associated 
factors also contribute to guidance in addition to active astrocytic processes[130]. 
To further understand how aligned astrocytes result in increased neuron 
outgrowth, studies on the influence of alignment on astrocyte physiology have 
been performed. Culturing astrocytes on a grooved poly(methylmethacrylate) 
substrate led to a decrease in GFAP expression in astrocytes. While few cells 
adhered, there was marked alignment of astrocytes and decreased cell viability 
and proliferation[148]. Similarly, astrocytes cultured on PCL nanofibers had 
diminished GFAP reactivity, although they did demonstrate increased adhesion 
on these surfaces[149]. Astrocytes grown on collagen nanofibers also exhibited 
similar behavior with an increase in astrocyte elongation and decreased GFAP 
expression 3 and 7 days post-injury. When placed in vivo as a rolled NGC, these 
devices demonstrated little GFAP staining within the spiral lumen of the device 
when compared with the device borders[112]. This result indicates either little 
astrocyte infiltration or maintenance of less reactive phenotypes. 
In vitro evidence indicates that aligned astrocytes may also aid NGC 
function. Artificial collagen constructs containing physically aligned astrocytes 
align subsequent neuronal outgrowth on those collagen gels[147]. Additionally, 
when associated with DRG neurons, astrocytes that are given a stimulus to 
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migrate away were shown to stretch, dislodge, and even tear neuronal processes 
during their migration[8]. Therefore, preserving an intact astrocyte structure 
would prevent this type of neuronal loss. When neurons were placed on 
astrocytes aligned by grooved PCL with features 12.5 or 25.0 μm in width, 
neuron outgrowth was aligned with the “buried” topography and persisted for 3 
weeks. Besides this directionality, it is vital to note that neurons simply cultured 
on the grooved PCL surfaces did not survive longer than 1 week[150]. Therefore, 
stimulating a population of aligned astrocytes in the SCI wound could allow for 
improved neuronal survival and directional growth. There has been conflicting 
evidence of this based on in vivo observations of the population of NGCs by 
astrocytes. Collagen-based fibers planted into the spinal cord showed little 
infiltration of GFAP positive cells even though neurons did extend onto the 
device[113,151]. Conversely, a PLA‒nanofiber NGC had astrocyte process 
extension concurrently with neuronal growth[128]. The same lab further explored 
the impact of their fibers on astrocyte behavior and found that astrocytes aligned 
by fibers had increased migration rates and neuroprotective glutamine uptake 
rates[133]. They also showed that aligned fibers increased astrocyte cellular 
extensions to 200 µm. 
As mentioned above, surface patterning with directional patterns of ECM 
molecules such as LN and FN is effective for aligning astrocytes, although 
surface patterned NGCs have yet to be tested in vivo. A study varying the width 
of stripes in patterns for aligning confluent astrocyte layers revealed the best 
alignment with 50 µm stripes of laminin, the widest stripe available for their study, 
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with 17 µm spacing between them[152]. Additionally, 15 µm stripe and spacing 
patterns also aligned astrocytes and transferred directional information through 
multiple astrocyte layers[130]. Thus, the ability to guide initial astrocyte 
attachment and growth could subsequently bias the implant surface to align 
additional astrocyte tissue layers and be more permissive for subsequent 
neuronal regeneration. While such evidence indicates a general size range for 
astrocyte aligning patterns, I wished to observe how astrocytes interact with 
surface patterns and the extent of their cellular extensions to understand the size 
of patterns that these cells can encounter upon attachment to a surface. In 
Chapter 4, I observed individual astrocytes with time-lapse microscopy as they 
attached to surfaces. The captured images allowed quantification of astrocyte 
spans and migration rates.  As cellular behavior will likely be dependent on 
underlying molecules, I used mixed gradients of laminin, which is traditionally 
adhesion permissive, and aggrecan, a neuron inhibitory CSPG, to test how 
astrocytes attached and moved on patterned substrates. I hypothesized that in 
the process of sampling the surface, astrocytes would prefer to attach to laminin 
over CSPG. 
 
1.7. Dissertation Overview 
As the roles of astrocytes in SCI are increasingly understood, the benefits 
they provide toward recovery have reduced the previously negative perception 
once held towards them. Direct injection and scaffold-based applications of 
astrocytes have resulted in improvement in SCI outcomes in vivo. There is also 
24 
 
cellular evidence that the efficacy of a neuron promoting NGC material is in part 
due to guidance of astrocytes that concurrently populate the devices. Numerous 
in vitro studies have demonstrated the ability of astrocytes to both improve 
neuronal outgrowth distance and provide directionality. This effect may be partly 
attributed to astrocytes having a reduction in reactivity when grown in a 
directional environment. Astrocytes will be prevalent in the glial scar that forms 
after injury and after implantation. By designing materials to reduce astrocyte 
CSPG expression, neurons may have one less barrier towards recovery. 
The goal of this research was to demonstrate and measure the impact of 
surface protein patterns on astrocyte reactivity in an effort to reduce neuron-
inhibitory CSPG production. To complete this endeavor, I first correlated CSPG 
expression in astrocytes as a token indicator of reactivity resultant from TGF-β 
exposure in Chapter 2. By inhibiting TGF-β type I activin receptor-like kinase 
receptors, CSPG production was decreased[153]. Interestingly, I found that 
astrocytes specifically identify FBG and selectively remove it from the glass 
surfaces from amongst other adsorbed blood proteins regardless of downstream 
signaling. While varying densities of FBG patterned on surfaces had no clear 
effect on overall CSPG production, I observed that astrocytes preferentially 
secreted CSPG onto FBG contacting surfaces. 
As directional surface protein patterns decrease astrocyte inhibition of 
neurons on glass, I patterned collagen hydrogels with similar designs to 
investigate the impact of patterns on CSPG expression. A cross-linked patterning 
method based on microcontact printing was developed in Chapter 3 to prevent 
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astrocyte removal of patterns, as seen in Chapter 2, from the collagen. Protein 
patterns on glass can be cross-linked and transferred to collagen by allowing 
gelling on top of the pattern and then using a peel-off technique to create free 
collagen sheets bearing the pattern on one surface. Stripe patterns of various 
ECM molecules aligned astrocytes on gel surfaces and reduced overall astrocyte 
CSPG expression[154]. This new method allows for the translation of any protein 
pattern developed on glass to be transferred to collagen. 
 Lastly, astrocyte attachment and migration were measured in real time to 
understand astrocyte substrate preference and their morphological 
characteristics as they initially interact with patterned surfaces. Such 
measurements may inform future pattern designs for guiding astrocyte 
attachment and alignment. Random dot gradients of mixed cues were developed 
to assess surface protein preference for astrocyte adhesion[155]. These 
measurements revealed that astrocytes prefer adhering to laminin over aggrecan, 
a CSPG, and will shift their cell bodies to do so. These findings also showed that 
astrocytes initially spread multiple processes upon attachment and are capable 
of spanning an average of 150 micrometers to sample surface patterns. These 
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Figure 1.1. SCI recovery timing and relative inflammatory events. A) Anatomic 
and functional outcomes. B) Macrophage activation and accumulation. Dotted 
lines are for studies from mice and solid from rats when there was a discrepancy 
between species. C) Expression of proinflammatory markers. D) Expression of 
neurotrophic factors. E) BBB permeability to α-aminoisobutyric acid (AIB; 104 
Da), horseradish peroxidase (HRP; 44,000 Da), and luciferase (61,000 Da). 
Dotted lines represent levels in white matter and solid lines report grey matter 










Figure 1.2. Nerve guidance device modifications and strategies to improve 
functional outcomes. Developments on the initial tubular design have been made 
to incorporate additional cues to promote neuronal recovery provide directionality. 





ASTROCYTES SPECIFICALLY REMOVE SURFACE-ADSORBED 




Surface-adsorbed fibrinogen (FBG) was recognized by adhering 
astrocytes, and was removed from the substrates in vitro by a two-phase removal 
process. The cells removed adsorbed FBG from binary proteins’ surface patterns 
(FBG + laminin, or FBG + albumin) while leaving the other protein behind. 
Astrocytes preferentially expressed chondroitin sulfate proteoglycan (CSPG) at 
the loci of fibrinogen stimuli; however, no differences in overall CSPG production 
as a function of FBG surface coverage were identified. Removal of FBG by 
astrocytes was also found to be independent of transforming growth factor type β 
(TGF-β) receptor based signaling as cells maintained CSPG production in the 
presence of TGF-β receptor kinase inhibitor, SB 431542. The inhibitor decreased 
CSPG expression, but did not abolish it entirely. Because blood contact and 
subsequent FBG adsorption are unavoidable in neural implantations, the results 
                                                          
*
 Reprinted from Acta Biomaterialia, Vol 9, Iss. 7, pp. 7200-7208, © 2013 with 
permission from Elsevier. 
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indicate that implant-adsorbed FBG may contribute to reactive astrogliosis 
around the implant as astrocytes specifically recognize adsorbed FBG. 
 
2.2. Introduction 
Neural implants elicit the foreign body response of the central nervous 
system (CNS), leading to a loss of local neurons [1] and [2]. The CNS response 
to implants is characterized by acute activation of microglia and astrocytes within 
one day of injury. Edema and debris are lessened within 1 week; however, 
chronic inflammation persists around these devices, and they become 
encapsulated by macrophage-like cells after 4 weeks [3]. This persistent, stable 
sheath of tissue, termed the glial scar, is composed of astrocytes and microglia. 
In the case of recording or stimulating electrodes that are implanted in the brain, 
degradation of electric signal quality has been attributed to this foreign body 
response and associated neuronal loss [1]. 
Initial CNS response to the neural implant can provide insight into the 
mechanism of glial scar formation. A universal feature of neural implants is that 
the initial surgical intervention during implantation causes hemorrhage and/or 
leakage of the blood–brain barrier (BBB). This effect may be compounded if the 
BBB remains compromised, allowing continuous contact of the device with blood. 
Like all materials exposed to blood, surfaces of such implants quickly adsorb 
plasma proteins at the blood–implant interface. Among the dozen plasma 
proteins with concentrations greater than 1 mg ml−1, fibrinogen (FBG, 2–3 mg 
ml−1 in blood plasma) plays a key role in hemostasis after injury and is known to 
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be a surface active protein that readily adsorbs to surfaces [4]. In circulation, 
FBG adsorbs to the surface of implants and often undergoes conformational 
changes that lead to adhesion and activation of platelets [5]. Fibrinogen 
adsorbed onto the surface of neural implants is ultimately exposed to the CNS 
tissue and not to blood. The question is whether CNS astrocytes recognize 
adsorbed FBG and react by mounting CNS inflammatory response. Such 
recognition could be one of the initial steps in the formation of a glial scar that 
ultimately results in an inhibition of neuronal activity around implants. 
Astrocytes in vivo have minimal glial fibrillary acidic protein (GFAP) 
expression in their quiescent state [3] and [6]. In reactive astrogliosis, however, 
GFAP expression is increased and astrocytes display hypertrophied morphology. 
Interestingly, astrocytes cultured in three-dimensional (3-D) collagen gels mimic 
more closely their in vivo state, while in two-dimensional (2-D) cultures in vitro 
they appear as being reactive [7]. In addition to their morphological changes, 
reactive astrocytes proliferate and secrete various factors and macromolecules. 
Of these secreted species, chondroitin sulfate proteoglycan (CSPG) is of 
particular interest as it has been implicated as a potential inhibitor of neuronal 
regeneration [8] and [9]. The modes of astrocyte expression of CSPGs can be 
varied. For example, brevican CSPGs are attached to the astrocyte membrane [9] 
and [10] while other CSPGs, like neurocan, are shed into cell media and were 
also found bound to underlying substrates [11]. 
Soluble chemical signals are also potent contributors to astrogliosis [12] 
and [13]. For example, transforming growth factor type β (TGF-β) is known to 
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trigger astrocyte activation. In this role TGF-β has been utilized to enhance in 
vitro models of the glial scar for neuronal outgrowth studies [14]. It has recently 
been shown that soluble blood FBG is a source of latent TGF-β; BBB leakage of 
soluble FBG into the CNS causes an increased CSPG expression in astrocytes 
both in vivo and in vitro by the TGF-β-mediated smad signaling pathway [15]. 
While it has been demonstrated that astrocytes can become reactive without 
BBB leakage by addition of a neurotoxicant [16], the FBG/TGF-β/smad activation 
pathway seems likely to be involved when neural implants covered with adsorbed 
blood proteins, including FBG, interface with CNS tissue. 
The objective of the present study was to find how astrocytes respond to 
adsorbed FBG and determine if this causes astrocytes to become more reactive 
and change their CSPG production. To investigate this particular scenario, we 
cultured astrocytes on surface-adsorbed FBG layers at different protein surface 
coverage. We found that the cells, after some initial incubation period, start to 
actively remove adsorbed FBG and locally produce CSPG. To test the role of 
latent TGF-β on adsorbed FBG recognition, we blocked the TGF-β receptors by 
an inhibitor of TGF-β receptor kinase. This blocking did not alter FBG removal by 
astrocytes nor completely abolish expression of CSPG in vitro, thereby indicating 







2.3. Materials and Methods 
2.3.1. Cell culture 
Primary cortical astrocytes were harvested from P1 Sprague–Dawley rats 
according to the protocol approved by University of Utah Institutional Animal 
Care and Use Committee [17]. Briefly, cortical tissue with removed meninges 
was broken up and digested in collagenase (1.33%, Worthington) for 30 min. 
Cortices were then treated with trypsin (0.25%, Worthington) for 30 min, triturated, 
suspended and plated in 75 cm2 tissue culture flasks. To purify astrocyte cultures, 
flasks were shaken overnight at 175 rpm after 1 week of culture post-dissection. 
After shaking, astrocytes were dissociated with 0.25% trypsin–EDTA (Gibco) and 
either frozen in liquid N2 or prepared for use. Cultures were verified for astrocyte 
populations with anti-GFAP immunostaining (1:1000, Chemicon). Cells were 
maintained in DMEM/F12 (Gibco) supplemented with 10% fetal bovine serum 
(FBS, Sigma). Astrocytes had media exchanged once every 2 days and were 
cultured for 1 week prior to use in experiments. 
Cells were seeded onto prepared coverslips in a 12-well tissue culture 
plate (CellTreat) at a density of ∼10,000 cells cm−2. This density was used to 
maintain sparse culture and minimize intercellular interactions. Astrocytes were 
seeded and cultured in DMEM/F12 with three types of conditions: (a) 10% FBS, 
(b) 10% FBS with 1% DMSO (Sigma), and (c) 10% FBS with 10 mM TGF-β 
receptor kinase inhibitor (SB 431542, Sigma) in 1% DMSO to block TGF-β 
signaling. Cells were cultured on experimental substrates for 48 h and then fixed 
with a 4% paraformaldehyde (PFA, Sigma) solution for 15 min. 
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2.3.2. Substrate preparation 
Human plasma fibrinogen (plasminogen depleted, Calbiochem) was 
fluorescently labeled with Alexa Fluor 594 (A-20004, Invitrogen) by reacting at 
room temperature for 2 h in 0.1 M sodium bicarbonate solution. The solution was 
eluted in phosphate buffered saline (PBS) through a PD-10 Sephadex column 
(GE Healthcare) to separate labeled protein from free dye. Collected fibrinogen 
solution (2 mg ml−1) was then filtered through a 0.2 μm syringe filter (Sarstedt), 
divided into 100 μl aliquots, and stored at −20 °C until use. Laminin (L2020, 
Sigma–Aldrich) solution was prepared in a 100 μg ml−1 concentration in PBS. 
Laminin was fluorescently labeled using Alexa Fluor 488 (A-20000, Invitrogen). 
For albumin studies, bovine serum albumin (68700, Proliant) was dissolved in 
PBS at 4.5 mg ml−1 and was also labeled with Alexa Fluor 488. 
Glass coverslips (Fisherbrand, 18 mm #2, Fisher) were rinsed in acetone, 
ethanol and DDI water before being sonicated in DDI water for 15 min. 
Coverslips were then dried in N2 and autoclaved. For samples with single 
adsorbed protein (fibrinogen or laminin), protein solution was applied over the 
surface and allowed to incubate at room temperature for 1 h. Autoclaved 
coverslips without adsorbed proteins were used as controls. For samples with 
added soluble TGF-β, human TGF-β 1 (R&D Systems) was added to culture 
media at 20 ng ml−1 at time of seeding. 
Microcontact printing (μCP) was used to create surfaces with different 
FBG coverage [18]. Patterns of randomly distributed μm-sized islands with 
coverage of 30% and 50% were made using soft lithography [19]. The 30% and 
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50% random distributions of pixels were first created in Mathematica (Wolfram). 
These pixels were then converted to a template for a photolithography mask 
where each pixel equated to a ∼1 μm2 feature. The mask served as a mold for 
polydimethylsiloxane (PDMS) casting. PDMS (Sylgard 184, Dow Corning) was 
poured over the mask and allowed to cure at 100 °C. Cast PDMS was peeled 
from the mask and soaked in hexane, acetone and ethanol to remove unreacted 
siloxane molecules, dried in an oven and cut into stamps containing the desired 
coverage pattern. The stamps were then sonicated in detergent solution 
(Alconox), rinsed with DDI water, and stored in DDI water prior to use. For use in 
μCP, the stamp was incubated in FBG solution (2 mg ml−1) at room temperature 
for 20–30 min, then briefly rinsed with DDI water and dried with an N2 stream. 
Stamps were brought into conformal contact with sterilized coverslips for ∼1 min 
for protein transfer. Upon stamp removal, the patterned coverslips were 
backfilled with laminin solution. The created FBG patterns are shown in Fig. 2.1. 
The coverage of proteins was 100% FBG (FBG100/LN0), 50% FBG with LN 
backfill (FBG50/LN50), 30% FBG with LN backfill (FBG30/LN70) or 100% LN 
(FBG0/LN100). This same protocol was followed to create binary FBG and 
albumin surfaces except that the labeled albumin solution was used for backfill 
after stamping. All substrates were then immediately used for cell culture. 
 
2.3.3. Time-lapse microscopy 
Astrocytes were seeded onto sterile glass-bottomed culture dishes 
(Fluorodish, WPI Inc.) that had been covered with micro-contact printed and/or 
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adsorbed proteins as described above. Cells were allowed to attach for 4 h and 
then imaged with an Olympus IX81 microscope on a temperature-controlled 
stage. Metamorph software (Molecular Devices) was used to take images of 
multiple stage positions once every 6 min for 20 h. Live cell images were taken 
with a 20× DIC objective and overlaid with corresponding fluorescence images. 
Time-lapse fluorescence images were brought in register manually to 
compensate for sample drift and were used in calculating fibrinogen removal 
kinetics. Areas of 5 × 5 pixels from five different cell regions of a given cell were 
tracked through time for analysis and used in calculation of the FBG removal rate 
according to the equation: 
     (1)  
where θ(t) is the surface coverage of FBG (assumed to be proportional to the 
fluorescence intensity) measured as a function of time t, θ0 is a final FBG 
coverage at the time when rapid removal process is finished, A is a removal 
coefficient and τ is a characteristic time for this removal process (τ = the inverse 
of the FBG removal rate constant). The initial time, t0, is defined as the time 
when the cell began to rapidly remove FBG and was determined as the point 
where there was a rapid fluorescence intensity change in the θ(t) curves. 








Astrocytes were fixed with 4% PFA for 15 min and rinsed in PBS with 0.1% 
sodium azide prior to immunocytochemical staining. All procedures were carried 
out at room temperature. Samples were first blocked with 4% goat serum in PBS 
for 1 h then rinsed thrice in PBS with azide. Primary anti-chondroitin sulfate (CS-
56) antibody (C8035, Sigma) was applied to the fixed astrocytes for 1 h at a 
1:500 dilution in block solution. Samples were again rinsed three times in 
PBS/azide and the secondary goat anti-mouse IgM antibody labeled with Alexa 
Fluor 488 (A21042, Molecular Probes) was subsequently applied to the samples 
for 1 h. Following three more PBS/azide rinses, DAPI (Invitrogen) at a 1:100 
dilution was added for 15 min to stain for nuclei. Samples were then rinsed in 
DDI water, allowed to dry and mounted onto 3″ glass microscope slides (VWR) 
with Fluoromount-G (Southern Biotech) for fluorescence imaging. 
 
2.3.5. Astrocyte surface CSPG expression 
Stained CSPG samples were imaged using a Nikon Eclipse E600 
epifluorescence microscope with a 20× PlanApo objective and CCD camera 
(CoolSNAP, Photometrics) using identical exposure times with blank images 
subtracted. Ten sample images were taken per condition. Each image was 
divided into six equal regions for quantification. The fluorescence intensity in 
each region was quantified using ImageJ (NIH). The integrated CSPG 
fluorescence intensity was normalized by dividing it by the number of cells per 
region as identified by DAPI nuclear stain. To correct for regions where no cells 
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were present and also regions with high densities of cells, ten regions with the 
highest and five regions with the lowest CSPG per cell values were removed 
from the analysis. An ANOVA with a Tukey post hoc test (α = 0.05) was used to 
determine the significance of data differences. To assess the 3-D distribution of 
CSPG fluorescence, a confocal microscope (Olympus BX61WI, 40× PlanFLN, 
NA 1.30) was used to image samples using multiple slices in the vertical, z-
direction. Image stacks were then compiled using Olympus Fluoview software. 
Vertical distribution of FGB and CSPG was measured at nuclear (as confirmed 
by DAPI), cell periphery and regions where cells deposited CSPG and then 
migrated away. For each region the fluorescence intensity was averaged over an 
area of 25 by 25 pixels in each z-slice. 
 
2.3.6. Expression of shed CSPG 
Radioactive sulfur assay was used to determine the amount of 
glycosaminoglycans (GAGs) shed by astrocytes into media vs. the GAG amount 
present on the cell membrane [20]. Astrocytes were cultured for 48 h in F-12 
nutrient mixture (Gibco) with 10% dialyzed FBS supplemented with 700 μCi of 
[35S] Na2SO4 (Perkin Elmer Life Sciences). Cells were cultured in T75 flasks on 
tissue-culture polystyrene (TCPS) with or without pre-adsorbed FBG layer. After 
the culture period, the conditioned medium was removed for GAGs analysis and 
the remaining cells were treated with 1 mg ml−1 pronase solution (Pronase 
Streptomyces griseuswas, Sigma–Aldrich) for endogenous GAG quantification. 
Each sample was purified for GAG chains using a DEAE-Sepharose (Amersham 
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2.4.1. Astrocyte removal of adsorbed fibrinogen 
Astrocytes adhered to fibrinogen-covered surfaces and subsequently 
removed the fibrinogen, as evidenced by progressive loss of fluorescence over 
time. This behavior was observed in real time via time-lapse microscopy and was 
also evident in fixed samples (Fig. 2.2). Fig. 2.2A–C (DIC + FBG fluorescence) 
shows the progress of fibrinogen removal from 4 to 23 h post seeding. Astrocyte 
adhesion to FBG-coated surfaces was a dynamic process with cells attaching to, 
detaching from and migrating across the surface throughout 24 h of culture. The 
initial 4 h of culture were used to allow for cells to attach to the substrates prior to 
imaging. At the 4 h time point, however, some regions depleted of FBG were 
already present on the substrates. Some of these sites had astrocytes attached, 
while others did not have any cells remaining on the FBG depleted sites. 
Adsorbed FBG removal by astrocytes was found to be a two-step process 
characterized by an initial gradual decrease of FBG fluorescence followed by a 
more rapid decay of fluorescence intensity (Fig. 2.3). The rapid FBG removal 
phase, when modeled as exponential intensity decrease (Eq. (1)), had a 
characteristic time, τ = 1.69 ± 0.46 h (mean ± standard deviation) over the five 
sub-areas across the cell (Fig. 2.3B and E). Similar FBG removal phases were 
found on patterned surfaces as well (Fig. 2.3C and D). The rapid removal only 
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occurred after an incubation period that varied as the cell migrated along the 
substrate (which contributed to dispersion in τ values). The initial slow FBG 
removal had an average dθ/dt slope of −0.0064 ± 0.0033 h−1 (mean ± standard 
deviation) and the duration of the slow FBG removal phase varied from cell to 
cell. 
In fixed and stained samples, FBG was seen as being selectively removed 
in the areas that were frequently co-localized with adhered cells. Such astrocyte 
behavior was independent of blocking TGF-β receptor type I, as astrocyte 
cultures treated with SB 431542 showed similar substrate modification. There 
was also sporadic evidence of cellular uptake of FBG in fixed samples as shown 
by areas of increased fluorescence associated with astrocytes (Fig. 2.4A and B). 
 
2.4.2. FBG removal is a protein-specific astrocyte response 
The specificity of astrocyte recognition and removal of adsorbed FBG was 
tested by comparing the effect of astrocytes on laminin (LN) and albumin (ALB) 
coated surfaces. These two proteins also provided a test for proteins larger and 
smaller than FBG. Adsorbed laminin is known to present the sites for astrocytes 
adhesion [21], and the cells spread more readily on laminin surfaces when 
compared to surfaces covered with FBG or serum proteins alone. Unlike FBG, 
surface-adsorbed laminin remained minimally modified by astrocytes over the 
culture period (Fig. 2.2D). The modification of surface fibrinogen by astrocytes 
was therefore not merely a result of cellular adhesion. 
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Similarly, astrocyte culture on a mixed albumin–fibrinogen substrate with 
50% ALB and 50% FBG coverage left albumin largely intact while still removing 
FBG (Fig. 2.4C and D). Thus astrocytes specifically removed the FBG from 
amongst the albumin, and left albumin in its original surface patterns. Adsorbed 
albumin and laminin results indicated that astrocyte did not use any nonspecific, 
broad-target proteolysis to remove FBG. Instead, the removal of FBG by 
astrocytes appeared to be a selective process that was unaffected by the 
presence of other proteins. 
 
2.4.3. CSPG expression in response to surface coverage of fibrinogen 
The cell-associated CSPG production was not significantly dependent on 
the amount of adsorbed fibrinogen presented to the cells (Fig. 2.5). Astrocytes 
expressed CSPG on all four substrates used for cell culture: full-coverage 
fibrinogen (FBG100/LN0), 50% coverage FBG backfilled with LN (FBG50/LN50), 
30% coverage FBG backfilled with LN (FBG30/LN70) and full-coverage laminin 
(FBG0/LN100). The levels of CSPG production were comparable to those found 
on astrocytes cultured in culture media on glass coverslips alone (data not 
shown). However, astrocytes seemed to produce CSPG in a local response to 
adsorbed fibrinogen patterns. For example, on FBG50/LN50 and also on 
FBG30/LN70 substrates, astrocytes were often found to produce the higher 
levels of CSPG by depositing it in between the random FBG patches (Fig. 2.6A, 
arrows). Astrocyte production of cell-associated CSPG was largest in the areas 
where cell membrane made contact with FBG. This behavior was consistent 
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across both nuclear and peripheral regions of the cell. Confocal 3-D imaging 
showed that the vertical z-position of expressed CSPG coincided with the z-
position of fibrinogen (Fig. 2.6B–D). Cells also produced CSPG throughout their 
intracellular space in addition to membranes. CSPG was also found deposited on 
surfaces where the cells had previously been but were no longer present, as 
evidenced by a footprint of removed FBG but the lack of positive DAPI staining 
(Fig. 2.6D). Once FBG was removed from a region, CSPG expression by the 
adherent cell became more uniform and was similar to CSPG expression by cells 
on homogenous substrates. Importantly, CSPG was not found on areas without 
either a footprint or a nucleus of cells, indicating that CSPG was not merely shed 
into the solution and then re-adsorbed to the surface from the medium. 
 
2.4.4. TGF-β contribution to CSPG production in vitro 
To clarify the role of adsorbed FBG in TGF-β signaling of CSPG 
production by adherent astrocytes, a small molecule inhibitor, SB 431542, was 
used to inhibit TGF-β receptors with superfamily type I activin receptor-like 
kinase [22]. These receptors have been shown to mediate CSPG expression in 
astrocytes when latent TGF-β was provided by soluble fibrinogen [15]. Fig. 2.7 
shows that CSPG production was somewhat attenuated in cultures with added 
inhibitor but not eliminated. The only significant decrease in CSPG production 
per cell with inhibitor treatment was found on cells grown on substrates with low 
or no fibrinogen (i.e. on FBG30/LN70 and FBG0/LN100 substrates). In general, 
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the cells also maintained their ability to remove FGB from surfaces, even in the 
presence of the inhibitor. 
Adding extraneous, soluble TGF-β to the sparse astrocyte cultures in 10% 
serum showed no significant differences in the overall CSPG produced per cell 
on fibrinogen (FBG100/LN0)- and laminin (FBG0/LN100)-covered substrates (Fig. 
2.8). For a clearer understanding of how the produced CSPGs were distributed, 
scintillation counts of [35S] from astrocytes cultured for 48 h on TCPS coated 
with FBG were taken. The radioactivity counts showed that around four times as 
many GAGs were secreted into the culture media (206,556 counts min−1, cpm) 
as compared to remaining CSPGs associated with the cell (49,755 cpm on FBG-
coated TCPS). Similar [35S] counts were also found for TCPS control surfaces 
coated with serum proteins from 10% FBS (211,977 cpm for secreted vs. 58,950 
cpm for cell-bound GAGs). 
 
2.5. Discussion 
It has been shown that astrocytes respond to soluble fibrinogen leaked 
into the CNS by cleaving latent TGF-β that subsequently activates the smad 
signaling pathway leading to increased CSPG expression [15]. The present study 
showed that surface-adsorbed FBG is also recognized by astrocytes and 
removed away from surfaces as a part of the CNS inflammatory response. 
Furthermore, astrocytes removed adsorbed FBG both with and without TGF-β 
signaling inhibitor, SB 431542. Therefore, when present on the surfaces of neural 
implants and CNS biomaterials, adsorbed FBG is sufficient to incite astrocytes to 
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respond by FBG recognition and subsequent removal. The FBG removal was 
found to be a two-step process: an initial gradual decline followed by a more 
rapid phase. The rapid removal phase had a similar characteristic time constant, 
τ ∼ 1–2 h, when measured at different locations. The rapid removal only occurred 
after an initial period that varied as the cells migrated along the substrate1. No 
consistent evidence for cellular uptake of FBG was found in time-lapse 
experiments. Occasionally increased intracellular FBG fluorescence signals were 
seen due to cells that detached from the surface and passed through the field of 
view while still being suspended in medium. In studies where the cells were fixed, 
there were also few examples of FBG cellular uptake (Fig. 2.4A and B). At this 
stage, there is no information about the mechanism by which astrocytes removed 
and potentially digested adsorbed FBG; however, it is clear that the removal 
process was specific to FBG. The proteases present in the serum-containing 
media did not appear to influence the specific FBG removal. FBG used here was 
plasminogen-depleted to minimize the addition of excess plasmin. The 
characteristic patterns of FBG removal from the substrates were associated with 
astrocytes. Even if there was any removal of surface protein mediated by serum 
proteases, it was much less than what occurred with the cellular removal of FBG. 
Furthermore, the FBG removal was independent of presence of TGF-β receptor 
inhibitor. The phases of FBG removal indicated that the cells need some initial 
                                                          
1
 To reliably observe cell behavior, an initial 4 h of culture was used to allow for 
cells to attach to the substrates. In that initial time period, however, some regions 
of depleted fibrinogen but lacking cells were already present on the surface. 
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period for FBG recognition and mounting of the digestion apparatus for rapid 
FBG removal. 
Serum albumin uptake by astrocytes after BBB disruption has been 
implicated in altering astrocyte behavior and causing pathological neuronal 
outcomes [23]. Astrocytes have been shown to uptake soluble albumin both in 
vivo and in vitro by Ivens et al. [24]. Such albumin uptake led to epileptiform 
activity in brain tissues. The same study also showed that both type I and type II 
TGF-β receptors were involved in albumin uptake into the brain. There may be a 
role for FBG in epileptogenesis as soluble FBG also triggers the same smad 
pathways [15]. In the current study, some evidence of astrocytes uptake of 
labeled albumin was seen when the cells were visualized by albumin 
fluorescence (Fig. 2.4C and D), but any uptake of adsorbed albumin from 
substrates was much smaller than the extent of FBG removal. This may 
potentially be due to cells being cultured in the presence of 10% serum and thus 
having an abundance of soluble albumin to uptake. Similarly, the differences in 
albumin conformation when adsorbed to the surface may have changed its 
bioavailability. However, in all samples astrocytes maintained FBG recognition 
and removal in the presence of serum. 
The experiments showed that the responses of astrocytes to the FBG 
patterns were local: the cells that recognized and removed adsorbed FBG 
preferentially expressed CSPG on the locations of the FBG stimuli (Fig. 2.5 and 
Fig. 2.6). However, there was no apparent dose-dependence of CSPG 
expression on adsorbed FBG coverage (Fig. 2.7). On these samples, laminin 
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substrates had similar levels of CSPG production to the substrates with adsorbed 
FBG even though there was no evidence of laminin uptake by astrocytes. This 
was possibly due to CSPG binding to surface laminin, which is known to occur 
and has been well characterized in vitro [25] and [26]. The effect of such binding 
is likely minor in the present studies as the CSPG expression on LN substrates 
were not significantly greater than expression on FBS-coated glass substrates 
(data not shown). The binding of CSPG to LN could explain the presence of 
CSPG deposited in between the FBG patterns, but one would then expect that 
the bound CSPG would remain in such patterns even after FBG removal as the 
LN remains unchanged. On the contrary, CSPG expression by cells becomes 
more uniform after the underlying patterns are removed (Fig. 2.6). This suggests 
a specific deposition of CSPG in response to FBG that diminishes as the 
stimulus wanes. Another potential contributor to the similar levels of CSPG 
expression across surface types could be due to the presence of 10% serum in 
cell culture medium. The effects of growth factors, albumin and other blood 
proteins may have affected astrocyte phenotypes to the point where the influence 
of substrate proteins was less effective. In the CNS wound environment, however, 
the same serum proteins would also be present. Additionally, the effect of using 
SB 431542 to inhibit TGF-β could have been diminished if those same TGF-β 
receptors were inundated with albumin. This inhibitor treatment, however, did 
yield significant differences in CSPG expression for some samples (Fig. 2.7). 
CSPG expression is expected to be a dynamic process in the sense that 
the acute CSPG response to local FBG might have been attenuated over time. 
61 
 
Note that in the present study CSPG production was not observed in real time, 
but only after 48 h of culture and subsequent cell fixing and staining. In an in vivo 
study of CSPG production in a stab-wound-induced glial scar in the spinal cord, it 
was shown that 130 kDa neurocan production actually decreased in the first 48 h 
post injury in the spinal cord, although this behavior was different for different 
types of CSPG macromolecules [27]. The peak level of RNA expression for 
neurocan in astrocytes in vitro occurred at 12 h after soluble fibrinogen treatment 
and this expression then diminished to baseline levels by 24 h though neurocan 
secretion into media persisted up to 7 days [15]. 
Astrocytes migrated while removing FBG and were even seen detaching 
after modifying the surface. Because of cell detachment, there likely was even 
higher CSPG production than what was captured after sample fixation and 
antibody staining. The radioactive sulfur measurements indicated that about four 
times as much GAGs are produced by astrocytes and released in the medium, 
though no differences in secreted and membrane bound CPSG were found for 
astrocytes exposed to adsorbed FBG vs. FBS-only proteins. It is apparent, 
however, that there was local, membrane bound CSPG expression in the 
presence of FBG. Confocal imaging indicated that CSPG vertical position was 
coincident with the position of surface bound FBG (Fig. 2.6). This local 
expression on the μm scale suggests that the astrocytic response to FBG was 
not a sustained, global upregulation of CSPG but rather a defined, controlled 
increase on membrane regions exposed to adsorbed FBG. 
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A significant decrease in CSPG production by blocking TGF-β receptors 
with SB 431542 in astrocyte cultures was only found for the substrates with 
predominant laminin coverage (FBG0/LN100 and FBG30/LN70). Decreases in 
CSPG production were found on the other substrate types but were not 
statistically significant (Fig. 2.7). It has been shown that astrocytes themselves 
produce TGF-β [28] available for intercellular signaling, which would be affected 
by adding of the inhibitor. This autocrine TGF-β functionality of astrocytes may 
potentially be more causal in determining overall CSPG production than the 
surface adsorbed FBG or externally added TGF-β, as these particular 
experiments yielded no significant changes in CSPG production. Although TGF-β 
contributed to CSPG production, blocking of the receptor did not abolish all 
CSPG production. Reducing the amount of expressed CSPG is an active area of 
research as potential CNS injury treatment. One approach is the digestion of 
CSPGs by chondroitinase, which leads to improved neuronal regeneration and 
function [29] and [30]. Similarly, SB 431542 might be considered for local 
treatment of CNS injuries and implants to reduce CSPG expression and 
astrogliosis, but the myriad roles of TGF-β signaling in the CNS wound 
environment must first be further understood [31]. The results presented here 
indicate that the TGF-β signaling pathway was not entirely responsible for 
astrocyte activation and CSPG expression in vitro on substrates with 
predominant fibrinogen coverage as the cells continued to produce CSPG even 
with SB 431542 treatment. In fact, a large fraction (>75%) of the astrocytic CSPG 
expression remained after inhibitor treatment on all types of substrates. In the 
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case of neural implants, one can infer that astrocytes will respond to the foreign 
stimulus and continue to present inhibitory CSPGs, even without TGF-β signaling. 
The impact that fibrinogen has on long term CNS implants has yet to be 
determined. It has been shown that BBB leakage continues 12 weeks after 
implantation, as demonstrated by the continued presence of IgG in brain tissue 
[1]. While FBG is approximately twice as large as IgG, it is likely that, if the BBB 
is compromised, various proteins could enter and potentially adsorb to the 
implant surface. However, it is important to note that after long-term implantation 
astrocytes are found at a distance of ∼50 μm from the implant/tissue interface 
that is typically populated with microglia and macrophages [2]. Thus it is unclear 
whether astrocytes would be able to maintain long-term contact with implant 
surfaces. Regardless, based on the evidence presented here, astrocytes mount 
an initial removal of FBG from and deposition of CSPG on implant surfaces: 
events that may trigger the neuronal inhibition. 
 
2.6. Conclusions 
It was found that surface-adsorbed FBG is specifically recognized and 
removed by astrocytes. Thus, in addition to its roles in coagulation and carrying 
latent TGF-β in circulation, adsorbed fibrinogen also initiates cellular responses 
by CNS astrocytes. Astrocytes removed adsorbed FBG over the course of 
several hours, and such behavior was maintained regardless of the presence of 
a TGF-β signaling pathway inhibitor. This indicated that astrocytes maintain 
sensitivity to adsorbed FBG by some, yet unknown, TGF-β receptor-independent 
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mechanism. While the CSPG expression was not dependent on the amount of 
FBG presented on the substrates, there was evidence that astrocytes 
preferentially produce CSPG at FBG contacting parts of their cell membranes. 
Additionally, CSPG production was also maintained in the presence of the 
inhibitor. Based on the fact that blood contact and subsequent FBG adsorption is 
unavoidable in neural implantations, the present results indicate that implant-
adsorbed FBG will trigger astrocyte removal of FBG. This alone may lead to local 
CSPG expression at the implant-CNS interface and thus contribute to 
subsequent inhibition of neuronal activity around the implant 
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2.8. Appendix A. Figures with Essential Colour Discrimination 
Certain figures in this article, particularly Figs. 2.1–2.6 are difficult to 
interpret in black and white. The full colour images can be found in the on-line 






2.9. Appendix B. Supplementary Data 
Supplementary data associated with this article can be found, in the online 
version, at http://dx.doi.org/10.1016/j.actbio.2013.02.047. 
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Fig. 2.1. Three substrates created by microcontact printing or adsorption of FBG. 
(A) 30% fibrinogen coverage with laminin (unlabeled) backfill (FBG30/LN70) and 
(B) 50% fibrinogen coverage with laminin backfill (FBG50/LN50) surfaces. (C) 
100% coverage created by fibrinogen adsorption (FBG100/LN0). Scale bar 
indicates 50 μm for (A–C). (D) Histograms of the fluorescence intensity from 











Fig. 2.2. Astrocyte modification of FBG and LN coated substrates. (A–C) FBG 
removal (DIC + fluorescence) by astrocytes at 4 h (A), 16 h (B) and 23 h (C) 
post-seeding. (D) Laminin 100% substrate (FBG0/LN100) remains largely 
unchanged after 48 h of astrocyte culture. (E, F) FBG layers modified by 
astrocytes after 48 h of culture on FBG100/LN0 (E) and FBG50/LN50 (F) 










Fig. 2.3. Two-phase FBG removal process. (A) Initial (4 h post seeding) 
FBG100/LN0 substrate with cell outline. (B) Same region of FBG100/LN0 surface 
at 24 h post seeding with updated cell outline. Five regions (5 × 5 pixels) used in 
analysis of removal kinetics are indicated. (C) Initial FBG50/LN50 substrate (LN 
unlabeled) with outlined cell in early phases of spreading. (D) Same region 
FBG50/LN50 surface after 14.5 h of culture showing cell outline and removal of 
underlying FBG layer. Scale bar: 25 μm. (E) Plot of normalized fluorescence 













Fig. 2.4. Confocal images of fixed and stained samples showing astrocyte 
removal of FBG taken 48 h after seeding. (A) Majority of cells removed FBG (red) 
without any visible intracellular uptake. (B) Smaller fraction of cells showed 
increased FBG (red) fluorescence in otherwise dark cell footprint regions. (C, D) 
On a binary protein surface pattern (FBG + albumin) astrocytes did not alter 
albumin (green) to the degree of removing FBG (red) over 48 h. Cell nuclei were 
DAPI stained (blue). Yellow square in (D) indicates location of (C). Scale bars: 













Fig. 2.5. Fluorescence images of fixed and stained samples showing the removal 
of FBG (red) and expression of CSPG (green) on FBG100/LN0 (A), FBG50/LN50 
(B), FBG30/LN70 (C) and on FBG0/LN100 (D) substrates. Cell nuclei were DAPI 














Fig. 2.6. (A) Confocal images stack of a representative fixed and stained sample 
showing CSPG (green) production on the FBG50/LN50 substrate (FBG in red, 
nuclei in blue). Yellow lines indicate the planes for z-projections shown beside 
and below in A. CSPG deposition was high in between the FBG patches prior to 
FBG removal (arrows). Scale bar: 25 μm. (B and C) Normalized vertical (z) 
intensity profiles show the peak CSPG intensity coinciding with peak FBG 
intensity at both the nucleus position (marked ∗1 in A, plot B), the periphery of 
cell (marked ∗2 in A, plot C), and in the region where the cell was no longer 











Fig. 2.7. The effect of TGF-β receptor kinase inhibitor SB 431542 on CSPG 
expression per cell on substrates with different FBG/LN coverage. Solid 
horizontal lines indicate the mean, and filled or empty points denote absence or 











Fig. 2.8. The effect of solution added TGF-β in DMEM/F12/10% FBS 
media + DMSO on CSPG production. CSPG staining per cell data were 
normalized to FBG0/LN100 sample. Error bars indicate ±SEM. Asterisk denotes 





ASTROCYTES ALIGNMENT AND REACTIVITY ON COLLAGEN  
HYDROGELS PATTERNED WITH ECM PROTEINS* 
 
3.1. Abstract 
To modulate the surface properties of collagen and subsequent cell–
surface interactions, a method was developed to transfer protein patterns from 
glass coverslips to collagen type I hydrogel surfaces. Two proteins and one 
proteoglycan found in central nervous system extracellular matrix as well as 
fibrinogen were patterned in stripes onto collagen hydrogel and astrocytes were 
cultured on these surfaces. The addition of the stripe protein patterns to 
hydrogels created astrocyte layers in which cells were aligned with underlying 
patterns and had reduced chondroitin sulfate expression compared to the cells 
grown on collagen alone. Protein patterns were covalently cross-linked to the 
collagen and stable over four days in culture with no visible cellular modifications. 
The present method can be adapted to transfer other types of protein patterns 
from glass coverslips to collagen hydrogels. 
 
                                                          
*





Glial cells facilitate neuronal guidance in recovering central nervous 
system (CNS) tissues and, from among them, astrocytes are known to form 
aligned networks which coincide with regenerating nerve tracts [1]. The poor 
recovery of neural functionality after CNS injury has been ascribed to the 
presence of inhibitory molecules as well as the formation of the disorganized 
tissue known as the glial scar [2], [3] and [4]. In response to CNS tissue injury, 
astrocytes become reactive and begin to express intermediate filaments as they 
hypertrophy. While this reactive scarring has beneficial roles, astrocytes also 
upregulate expression of extracellular matrix (ECM) molecules such as 
chondroitin sulfate proteoglycan (CSPG) that has been shown to inhibit neuronal 
regeneration [4]. One approach to improve CNS recovery is to treat the glial scar 
with chondroitinase, a broad enzyme that digests chondroitin sulfate, thus 
enzymatically removing the inhibitory components of the scar [5]. An alternative 
to that approach would be to add a biomaterial to the injury site so that injured 
neuronal cells could grow directionally and eventually re-establish lost 
connections [6]. Such a biomaterial should both facilitate re-establishing glial 
organization and promote neuronal regeneration. 
Collagen type I has been used extensively in treating injured CNS with 
devices ranging from dura replacement sheets to nerve guidance conduits. 
Collagen has been shown to be bioresorbable and easily incorporated by host 
tissue. Astrocytes themselves have been shown to deposit collagen in the CNS 
wound environment [7]. Collagen types I, III, and IV have been found in the glial 
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scar, though their presence alone is not inhibitory [8], [9], [10] and [11]. Collagen 
is also a permissive substrate for neuronal outgrowth and regeneration in vivo 
[12] and [13]. Used as a growth substrate in vitro, collagen has been used to 
create a scaffolding structure where a quiescent, unreactive astrocyte phenotype 
is preserved, as opposed to the more reactive, hypertrophic phenotype that 
occurs in standard 2D astrocyte culture [14]. Collagen has also been used as a 
scaffold material for cellular therapies including glial precursors [15], Schwann 
cells [16], and differentiated astrocytes [17]. 
Rather than implanting a simple biomaterial scaffold to a CNS injury site, 
the addition of other ECM components to the scaffold has been used to improve 
CNS recovery as reviewed by Volpato et al. [18]. Collagen has been augmented 
with various bioactive agents including brain-derived neurotrophic factor (BDNF) 
[19], neurotrophin-3 [20], fibroblast growth factor (FGF) [21], and chondroitinase 
[22], which have been cross-linked to collagen gels to improve neuronal 
outgrowth. Topographical cues, such as the direction of collagen nanofibers, 
have also been used to align and direct both astrocytes and neurons [23]. 
Neurons grown at the interface between collagen and ECM components 
patterned on glass showed that neurons followed associated ECM patterns and 
largely avoided penetrating deeper into collagen gels [24]. Thus, it seems that 
both the physical properties of collagen scaffolds and the presence of surface 
guidance cues are important for determining the CNS cellular response. 
Controlling astrocyte alignment and infiltration is a worthy goal for 
improving CNS regenerative biomaterial potential [21] and [25]. Astrocytes may 
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serve as a source for guidance cues and growth factors, and, as a large 
component to the glial scar, their behavior is important for wound healing and 
neuroprotection [26]. We have shown that even fixed aligned astrocytes will still 
direct neuronal outgrowth without having to release any active soluble factors 
[27]. As differentiated astrocytes seeded in collagen constructs have led to 
functional recovery in vivo [17], the ability of astrocytes to attach to and align on 
biomaterial constructs may foment subsequent directed neuronal outgrowth and 
promote regeneration. 
The present study aimed at imparting directional guidance cues to 
collagen gels in a relatively simple way so that astrocytes can attach and align 
themselves without increasing their reactivity so commonly seen in traditional 2D 
cultures. The method described here was used to covalently attach patterns of 
proteins or proteoglycans to collagen hydrogel surfaces. Similar approaches 
have been proposed for other polymers such as polydimethylsiloxane (PDMS), 
polyvinyl alcohol, polyacrylamide, and polycaprolactone [28], [29], [30], [31] and 
[32]. Recently, microcontact printing of proteins to freeze-dried Matrigel™ and 
gelatin has been demonstrated [33]. However, to the best of our knowledge, the 
present report is the first application of protein pattern transfer and covalent 
attachment to the surface of collagen type I hydrogels and requires no additional, 
specialized equipment beyond standard materials for creating protein patterns. 
The techniques described here will be conducive to the transfer of multiple 
proteins deposited in any desired pattern on glass surface by traditional 
microcontact printing [34], stamp-off [35], sequential stamping, microscope-aided 
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registration [36], dip-pen nanolithography [37], or inkjet deposition [38], directly to 
collagen hydrogel surface. 
 
3.3. Materials and Methods 
3.3.1. Collagen hydrogel patterning 
To visualize patterns transferred to the surface of collagen gels, proteins 
were labeled with fluorophores. Human plasma fibrinogen (FBG, plasminogen 
depleted, Calbiochem) and aggrecan (AGG, A1960, Sigma) were fluorescently 
labeled with Alexa Fluor 594 (A-20004, Invitrogen). Laminin (LN, L2020, Sigma–
Aldrich) and fibronectin (FN, F1141, Sigma–Aldrich) were labeled with Alexa 
Fluor 488 (A-20000, Invitrogen). To separate labeled protein from free dye, 
labeled protein solutions were eluted in phosphate buffered saline (PBS) through 
a PD-10 Sephadex column (GE Healthcare). Collected solutions were then 
filtered through a 0.20 μm syringe filter (Sarstedt), divided into 100 μL aliquots, 
and stored at −20 °C until use. 
To pattern the surface of collagen gels, a two-step process was used. 
Microcontact printing (μCP) was used first to pattern labeled proteins onto 
sterilized 18 mm glass coverslips [34] and [39]. The pattern used in this study 
consisted of 15 μm stripes separated by 25 μm–wide gaps. This pattern was 
selected as 15 μm stripes previously aligned astrocytes on glass [27], and the 
added asymmetry was useful to distinguish printed and non-printed regions while 
maintaining alignment [36]. In the second step, a process was developed for 
collagen to undergo simultaneous gelling and cross-linking while the protein 
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patterns were transferred (Fig. 3.1). Bis[sulfosuccinimidyl] suberate (BS3, 
Thermo Scientific) was prepared immediately before collagen gelling to minimize 
hydrolysis of its reactive groups. Two mg of BS3 was dissolved in double-distilled, 
deionized (DDI) water to a concentration of 50 mM. This BS3 solution was placed 
as a 10 μL droplet on top of the stamped proteins on the coverslip surface and 
then immediately followed by deposition of 100 μL collagen type I (BD 
Biosciences) solution at a concentration of 10 mg/mL to the top of the stamped 
coverslips. NaOH (1 M) was added to bring the gel to neutral pH according to 
manufacturer specifications. A PDMS sheet (0.005″ thick, Specialty 
Manufacturing Inc.) was placed on top of the gel to facilitate gel spreading and 
future handling. Gelling and cross-linking was allowed to proceed for 30 min at 
37 °C. The gel constructs were then placed in a humidified incubator to dry for an 
additional 48 h. The patterned collagen was separated from the stamped 
coverslip with the aid of physical force (i.e., using a cell scraper). To isolate 
patterned collagen gel alone, the construct was submerged in water and the 
hydrogel was lifted off the backing substrate using a fine brush. This procedure 
was successful with collagen gel concentrations ranging from 5 to 10 mg/mL, 
with higher concentrations being more amenable to physical manipulation. 
Removal was facilitated by releasing the entire circumference of the gel by 
scraping under its edge about a millimeter prior to attempting to separate it 
entirely from the substrate. By using the separated edges, a peeling motion from 
one side to the other, while ensuring that the gel was separating evenly, was 
effective. This also prevented damage to the center of the gel where images 
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were later acquired. A collagen concentration of 10 mg/mL, which has been 
shown to have physical properties relevant to CNS tissue [40], was used in this 
study to eliminate any further variation in gel stiffness. 
 
3.3.2. Cell culture 
Primary astrocytes from post-natal day 2 Sprague–Dawley rats were 
obtained using established protocols [41]. Confluent astrocyte cultures were 
shaken to remove contaminating cells and frozen. Astrocytes were thawed and 
cultured for 2 weeks prior to trypsinization and seeding onto collagen gels. 
Cultures were maintained in a humidified incubator at 37 °C and 5% CO2. 
Astrocytes were seeded on collagen gels at a density of approximately 25,000 
per cm2 in SATO- serum-free media [42] and allowed to attach for 5 h. After that 
time, medium was changed to DMEM/F12 (Caisson Labratories) with 10% fetal 
bovine serum (FBS, Atlanta Biologicals) for the remaining culture period. Medium 
was exchanged at 48 h, and the cultures were fixed at 96 h post-seeding. 
 
3.3.3. Immunocytochemistry for CSPG quantification 
Because real time phase or DIC microscopy of astrocytes on collagen gels 
were difficult due to extensive light scattering by the gels, cells on gels were fixed 
in 4% paraformaldehyde (PFA) for 15 min and rinsed in PBS with 0.1% sodium 
azide prior to immunocytochemical staining. All procedures were carried out at 
room temperature. Samples were blocked with 4% goat serum in PBS for one 
hour and then rinsed thrice in PBS with sodium azide. Primary anti-chondroitin 
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sulfate (CS-56) antibody (C8035, Sigma) was applied to the astrocytes for one 
hour in a 1:500 dilution in the block solution. Samples were again rinsed three 
times in PBS with sodium azide. Secondary goat anti-mouse IgM antibody 
labeled with Alexa Fluor 488 (A21042, Molecular Probes) or Alexa Fluor 594 
(A21044, Molecular Probes) was subsequently applied to the cell samples for 1 h. 
Following three more PBS rinses, 4′,6-diamidino-2-phenylindole (DAPI, 
Invitrogen) in a 1:100 dilution was added for 15 min to stain for nuclei. Samples 
were then rinsed in DDI water and mounted between coverslips (Fisher) with 
Fluoromount-G (Southern Biotech) for imaging. Astrocytes on plain collagen 
controls were divided into two batches for use with each type of secondary 
antibody. Fluorescence images were captured using a Nikon Eclipse E600 
epifluorescence microscope with a 20× PlanAPO objective and CCD camera 
(CoolSNAP, Photometrics). 
 
3.3.4. Quantifying astrocyte CSPG expression 
CSPG samples were imaged after staining using identical exposure times 
in Image Pro Plus (Media Cybernetics) software. A blank image was subtracted 
from each image and the CSPG fluorescence intensity was quantified using 
ImageJ (NIH). The CSPG fluorescence was integrated over the entire image and 
divided by the number of cells per image as identified by DAPI staining. Samples 
with fewer than five nuclei were not included in analysis. Images were taken of 
five sample sub-areas where protein patterns and cells were visible and on the 
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same focal plane. An ANOVA with a Tukey post hoc test (α = 0.05) was used to 
determine the significance of data differences. 
 
3.3.5. Astrocyte alignment analysis 
Astrocyte alignment was assessed by measuring the orientation of their 
nuclei [27] and [36]. To do this, the angle of the major axis of the oval-like 
astrocyte nuclei were quantified using the measure angle function of Image Pro 
Plus. Fig. 3.2 shows the measured angles (shown as line segments drawn at the 
measured angle and superimposed over outlined nuclei). Any nuclei that were on 
image edges that could not be fully resolved were excluded from analysis. The 
measured nuclei angles were then converted to an alignment angle with respect 
to the orientation of the underlying protein pattern. For collagen controls lacking 
protein patterns, the vertical axis was used as reference. The alignment angles of 
all nuclei across each given sample type were compiled into a histogram in 10° 
bins. A zero degree angle indicated nuclei that were completely parallel with the 
underlying patterns. Histograms were fit with a Gaussian function using Igor Pro 
(Wavemetrics) to find the mean alignment angle and the full width at half 
maximum (FWHM) for each nuclei population (FWHM is approximately equal to 








3.4.1. Protein patterns transferred to collagen gels and resisted 
removal by astrocytes 
The techniques described here created collagen gels with a covalently 
immobilized pattern of protein transferred from glass to one of the gels' surfaces. 
Stripe patterns of aggrecan (AGG), fibrinogen (FBG), fibronectin (FN), and 
laminin (LN) were all successfully transferred to the surface of collagen type I 
gels (Fig. 3.3). Fidelity of the pattern on gels required quality protein patterns on 
glass and careful manual removal of gels to maintain intact gel sheets. As loss of 
immobilized proteins from the gel surfaces would negate the benefit of patterning 
these gels, the patterns were imaged prior to and after 96 h of astrocyte culture 
to determine pattern integrity. No changes in the protein pattern appearance 
were observed over that time period. Unlike the removal of glass-adsorbed 
fibrinogen by astrocytes seen previously [43], proteins patterned on collagen 
were not removed by cells over the given culture time period. We infer that the 
protocol used created stable, immobilized protein patterns that did not diffuse into 
the gel or desorb/detach from the collagen surface. 
 
3.4.2. Astrocytes align with underlying protein patterns on collagen 
Astrocytes attached and spread onto collagen gel surfaces with and 
without immobilized protein patterns within the first 5 h of culture. After the 
addition of 10% serum and subsequent culture for 4 days, astrocytes oriented 
themselves on the gels. A degree of polarity and alignment was established 
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locally by the cells even on plain collagen gel controls (Fig. 3.2A) as astrocytes 
that were close together tended to align with each other in clusters. For samples 
with immobilized ECM protein patterns, a much stronger alignment was seen (Fig. 
3.2B). Only stripes of transferred protein differentiated these surfaces from plain 
collagen gel controls. A more quantitative measure of the astrocyte alignment is 
given by the histograms showing the fitted Gaussian function, mean angle, and 
FWHM values for each sample (Fig. 3.4). On the control collagen gels (Fig. 3.4A), 
astrocyte alignment was random with angles spread across all possible angles 
with a FWHM of 176.1°. In contrast, on gels with immobilized ECM protein stripes, 
the mean angle for astrocyte nuclei was within 8° of the orientation of the 
underlying pattern for each protein (Fig. 3.4F). The difference between the 
patterned proteins can be analyzed by the variations in FWHM where the 
smallest FWHM value indicated better alignment. Nuclei on the FBG pattern 
showed the narrowest orientation spread (FWHM of 37.6°, equivalent to a 
standard deviation of ±16°; Fig. 3.4C). FN and LN patterns (Fig. 3.4D,E) were 
less potent than FBG in aligning cells with FWHMs of 79.6 and 69.9°, 
respectively. The AGG pattern, which does not strongly align astrocytes on glass 








3.4.3. Astrocyte CSPG reactivity is attenuated with the addition 
of ECM proteins 
The overall CSPG expression by astrocytes was significantly lower on the 
ECM protein patterned gels compared with two sets of controls1 (Fig. 3.5). The 
presence of FBG and LN patterns led to a significant reduction (>50%) of CSPG 
expression. There was no significant CSPG reduction detected for the FN pattern, 
while on the AGG pattern the CSPG was reduced to about one-third of the mean 
CSPG expressed per cell for collagen control. As expected, in the case of AGG 
patterns, there was some staining of underlying AGG stripes with the anti-CS 
antibody. This fluorescence was included in the integrated CSPG fluorescence 
so the actual reduction of CSPG expression by astrocytes on AGG patterns 
could have been greater than shown in Fig. 3.5. 
 
3.5. Discussion 
3.5.1. Collagen gels with stripe patterns aid alignment of astrocytes 
As previously shown, neurons send outgrowths that follow aligned 
astrocytes and Schwann cells, as well as biomimetic artificial surfaces [44]. If one 
can use a biomaterial surface to align astrocytes and other glia, subsequent 
neuronal growth and layers of glia could then be guided as well. Using the 
method developed here for decorating collagen surfaces with ECM proteins, it 
would be possible to transfer any protein pattern prepared on a glass coverslip 
                                                          
1
 For imaging both the ECM protein pattern (see Fig. 3.3) and expressed CSPG, 
secondary goat anti-mouse IgM antibodies were either labeled with Alexa Fluor 
488 or Alexa Fluor 594. 
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surface to collagen. While others have aligned astrocytes in/on collagen via 
physical forces [25], the current protocol could be readily adapted to transfer 
multi-protein patterns, thus increasing the repertoire of the molecular cues for 
astrocyte alignment and/or neuronal outgrowth. 
As there were no added topographical cues on these patterned collagen 
gels, the alignment was caused by the molecules found on the surface of the 
gels. These could include the patterned proteins, ECM secreted by the cells, 
proteins from the culture medium, and collagen itself. The presence of adhered 
serum proteins could not be ruled out as all samples had the access to 10% 
serum containing medium. The 10% serum medium was introduced after the 
initial culture period of 5 h without serum. After this initial attachment period, the 
composition of the surface proteins might have been altered as both cells and 10% 
serum were present. Therefore, the actual mechanism as to how the patterned 
protein stripes functioned to align astrocytes could not be conclusively 
determined. It is clear, however, that the presence of these protein stripes 
causes nuclear alignment over plain collagen. 
Astrocyte nuclei were seeded randomly across the substrates, and were 
found to slightly favor the position where the nucleus is partially on the protein 
stripe pattern and partially off of it after culture. The pattern used in the present 
study had an unequal distribution of protein vs. collagen-only areas. For any 
given region, only 37.5% of the area (15/(25 + 15)) was covered with patterned 
protein stripes. The likelihood of the cell to attach to collagen alone was 62.5%, 
(25/(15 + 25)), almost twice than that for protein stripes. If a fully spread cell were 
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50 μm wide and was centered in the middle of a collagen stripe, it could sample 
both neighboring protein patterns on each of its sides. Conversely, if it finds itself 
in the middle of the protein stripe, it would only sample collagen on both sides. 
That may explain why some nuclei were found over the collagen regions 
between the protein stripes. However, the actual count of the nuclei positions 
showed no clear preference for collagen-only regions: the majority of nuclei were 
located over some portion of both collagen and the protein stripe. 
We have previously seen that adsorbed FBG was removed from glass 
surfaces below adhered astrocytes, most likely because of the protein was 
simply adsorbed to the surface [43]. In the case of immobilized FBG on collagen 
gel surface, astrocytes did not remove fibrinogen or any of the other three ECM 
proteins from the surface, indicating that the transfer procedure created stable 
crosslinks between the protein molecules and the gel surface. Likewise, 
crosslinks could have also formed between two collagen molecules or two 
patterned proteins with this technique. Regardless, the ECM proteins patterned 
here still maintained alignment potency after this process. 
The robust nature of transferred protein patterns, coupled with the 
tendency for guidance information to be carried from cell to cell, indicates that a 
collagen biomaterial device with appropriately oriented patterns could provide a 
scaffold for recovering CNS cells that could combat the default tissue 
disorganization that occurs in CNS injury. The underlying collagen itself could 




3.5.2. Astrocyte CSPG reactivity decreases with ECM alignment cues 
It is well known that in response to CNS injury, astrocytes acquire a 
reactive phenotype, which includes increased expression of glial fibrillary acidic 
protein (GFAP) and CSPG [4]. Although some variants of the chondroitin sulfate 
(CS) chains, such as CS-C, are inhibitory to neuronal outgrowth and others 
variants (CS-A and CS-E) are not [45], astrocyte expression of CSPG is 
correlated with their inhibitive properties to neurons. While CSPG are also shed 
into the surrounding cellular environment by astrocytes [43] and [45], the surface 
expression on their membranes is important for interfacing with neurons. It is 
therefore informative to determine if a CNS biomaterial scaffold itself is 
increasing astrocyte surface expression of CSPG. As compared with the collagen 
control, three ECM proteins — FBG, AGG, and LN—each able to align 
astrocytes to some degree, were also able to reduce this CSPG expression. The 
decrease in CSPG reactivity between unpatterned and patterned gels could have 
been caused by either the ECM molecule itself or the alignment of astrocytes it 
caused. Based on the previous reports that the introduction of FBG into the CNS 
after injury triggers CSPG production [46], and that fact that AGG already 
contains inhibitory CS chains, it appears that the alignment itself was the 
dominant contributing factor resulting in the decrease in CSPG expression seen 
here (Fig. 3.5). It has been shown that the presence of topographical cues that 
aligned astrocytes also reduced astrocyte reactivity [47]. Similarly, astrocytes 
grown on aligned electrospun fibers of polycaprolactone had decreased GFAP 
expression compared to those on random fibers [48]. The findings from the 
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present study thus indicate that astrocytes and their surface CSPG expression 
are sensitive to organized, directional cues. 
 
3.6. Conclusions 
Creating collagen gels with surfaces patterned with FBG and three ECM 
proteins was developed and tested on in vitro cultures of astrocytes. Patterns of 
FBG, AGG, FN, and LN stripes were able to align astrocytes when compared to 
collagen alone. Additionally, the aligned astrocytes on AGG, FBG, and LN 
patterns showed reduced overall CSPG expression. Astrocytes survived the 
entire 96 h culture period, leaving no indication of toxicity of this process. Other 
cross-linking agents like genipin [21] and disuccinimidyl-disuccinate-
polyethyleneglycol (SS-PEG-SS) [49], which have previously been used to link 
proteins to collagen, should be amenable to the protein pattern lift-off from glass 
coverslips. The method developed here will also allow transfer of multiple ECM 
molecules with any desired spatial presentation on collagen and the investigation 
of cellular responses. In this way, the method may find its application to 
biomedical devices where surface–cell interactions can be leveraged to improve 
patient outcomes. Collagen biomaterials with their surfaces decorated with 
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Fig. 3.1. Schematic of process for transferring protein pattern to collagen. A) The 
desired pattern is ﬁrst created on a glass surface after which B) BS3 crosslinker 
solution and collagen are placed on the pattern and spread with a PDMS sheet. 
C) The gel is allowed to crosslink with the pattern and then peeled from the glass. 
The PDMS backing can be removed leaving a D) stand-alone collagen gel with a 














Fig. 3.2. Astrocyte nuclei angle measurements. Representative images of 
astrocyte nuclei on A) unpatterned collagen control and B) collagen with 
ﬁbrinogen protein pattern. Areas between dotted lines marked with þ indicate 
regions with patterned FBG on collagen gel. Short lines drawn for each nucleus 














Fig. 3.3. Representative fluorescence images of astrocytes on patterned collagen 
gels. A,D) unpatterned collagen control; B) aggrecan (red) on collagen; C) 
fibrinogen (red) on collagen; E) fibronectin (green) on collagen; and F) laminin 
(green) on collagen gels were created. In panels A–C, CSPG (green) expression 
was measured using Alexa Fluor 488 labeled secondary antibody. In panels D–F, 
CSPG (red) was measured using Alexa Fluor 594 labeled secondary antibody. 
Nuclei (blue) can be seen in each image (A–F). Scale bar = 25 μm. (For 
interpretation of the references to color in this figure legend, the reader is 













Fig. 3.4. Astrocyte nuclei angle histograms on patterned collagen gels. The 
angles of observed astrocyte nuclei were compiled into histogram with 10° bins 
for A) unpatterned collagen control, B) aggrecan stripes, C) fibrinogen stripes, D) 
fibronectin stripes, and E) laminin stripes. The dotted curves indicate the 
Gaussian model fit for each data set. These fitted curves were used to calculate 











Fig. 3.5. CSPG expression by astrocytes on patterned collagen gels. Each dot 
represents CSPG fluorescence (in arbitrary units) integrated from a single 
fluorescence image. To account for the variations in cell numbers in each image, 
the integrated CSPG fluorescence from each image was divided by the number 
of cells present. CSPG was either visualized using Alexa Fluor 488 labeled 
secondary antibody for aggrecan and fibrinogen patterns, or Alexa Fluor 594 
labeled secondary antibody for fibronectin and laminin patterns. Unpatterned 
collagen controls for both fluorophores were used to allow for comparison 







ASTROCYTE SPREADING AND MIGRATION ON  
AGGRECAN-LAMININ DOT GRADIENTS 
 
4.1 Abstract 
 A surface gradient made of two ECM molecules was developed to 
understand the migratory and morphological responses of astrocytes to 
molecular cues typically found in the central nervous system injury environment. 
The gradient, prepared using microcontact printing, was composed of randomly 
positioned µm-sized dots of aggrecan (AGG) on a uniform coating of laminin (LN). 
The aggrecan patches were printed in an increasing number along the 50 µm 
wide, 1 mm long gradient. Each gradient was surrounded by a uniform region of 
aggrecan. Astrocytes seeded on gradients were found to attach to exposed LN 
patches in the gradient. Cellular extensions of the cells were longer than the 
processes found for cells seeded on uniform control surfaces. Astrocyte 
extensions were greatest and spanned a distance of 150 µm when they were 
attached to the mixed AGG+LN patches of the gradient. Astrocytes extended 
processes in a stellate fashion upon initial attachment and maintain extensions 
as evidenced by increased area and perimeter when presented with AGG+LN 
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but not with LN alone. The cells did not migrate large distances after initial 
attachment, only distances of around 20‒35 µm over 24 h, but preferentially 
shifted from areas of high AGG to high LN concentration regions. These findings 
indicate that presenting mixed ECM cues caused astrocytes to sample larger 




 After central nervous system (CNS) injury, resident astrocytes serve 
important functions to reduce damage by restoring homeostasis, sequestering 
invading cells, and preserving neuronal cells[1–3]. Astrocytes are also 
responsible for the neuron inhibitory extracellular matrix (ECM) rich in chondroitin 
sulfate proteoglycan (CSPG) that is produced following CSN injury[4]. These 
contrasting characteristics largely arise due to the heterogeneous nature of 
astrocytes and the varying time course of their roles as the neuroprotective 
impacts are overshadowed by CSPG production over the course of healing[2,5]. 
The ability of astrocytes to migrate in the recovering CNS environment and 
compact lesions has been shown to be beneficial to functional recovery[6]. 
Several approaches have been undertaken to understand how astrocytes 
migrate both in vivo and in vitro. Xenogenic astrocyte transplants into mice 
showed that astrocytes migrated at a rate of 220 µm/day before slowing[7]. 
Transplanted astrocytes from primary cultures actively entered multiple regions 
of brain tissue[8,9]. In contrast, there was no marked migration of cortical 
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astrocytes after stab wounds[10]. This lack of migration has also been observed 
in real time. After traumatic brain injury (TBI), live tracking of astrocytes showed 
that there was no bulk recruitment or migration of astrocytes to the wound site, 
but rather an increase in proliferation of cells adjacent to the injury[11]. However, 
a subset of astrocytes from the proliferative sub-ventricular zone were shown to 
migrate to ischemic cortex and have neuroprotective functions[12]. In vitro, 
scratch wound assays have been commonly used to investigate how astrocytes 
close gaps in confluent monolayers. Astrocytes at the edge proliferate but 
individual cells show limited movement[13]. They also upregulate ECM molecule 
production, especially laminin and CSPG[14,15]. This behavior leads to eventual 
closing of the defect. 
There is conflicting evidence regarding the role of astrocytes at the injury 
site. Astrocytes differentiated with bone morphogenetic protein that were placed 
in collagen scaffolds aided functional recovery after spinal cord injury in rats[16]. 
Conversely, application of collagen fiber-based scaffolds that also improved 
functional outcomes in canines showed that grafts were not heavily populated 
with astrocytes while neurons continued to be able to grow[17].  In contrast, 
polylactic acid (PLA) microfibers were shown to concurrently direct both astrocyte 
and neuronal growth when used to bridge a spinal transection[18]. While it is 
unclear if populating scaffolds with astrocytes is important for functional recovery, 
in vitro studies have been shown that aligned astrocytes increase outgrowth and 
convey directionality to neurons themselves[19,20]. Alignment of astrocytes and 
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a subsequent decrease in reactivity can be accomplished using electric fields, 
topographical features, and molecular cues[20–24]. 
Rather than a uniform coating of chemoattractant, a potential stimulus for 
guiding astrocytes onto scaffold surfaces could include a directional gradient 
containing attractive and/or repulsive molecular cues. Such surface gradients 
have been valuable in discovering neuronal behavior[25–28], which can be 
missed in the absence of subtle concentration changes of molecular cues[29]. 
Laminin has been shown to be supportive of astrocytes adhesion and 
migration[14], and aggrecan, a proteoglycan with CSPG chains, is often selected 
as a model inhibitory component. Aggrecan is produced by astrocytes and is 
known to inhibit Schwann cell migration[30]. Aggrecan has also been shown to 
have limited alignment effect on astrocytes[31]. In the present study, we utilized 
time-lapse microscopy to observe astrocytes after being seeded on randomly 
placed µm-size aggrecan patches printed on a uniform film of laminin. 
Microcontact printing was used to print these aggrecan patches in an increasing 
number along the 50 µm wide and 1 mm long area that was surrounded by a 
uniform field of aggrecan.  In this way, each gradient of aggrecan also contained 
a countergradient of laminin.  Random placement of aggrecan patches in 
gradients resulted in a lack of periodicity found in alternative designs[32–34]. 
Astrocyte migratory and morphological responses to the aggrecan/laminin and 





4.3. Materials and Methods 
4.3.1. Cell Culture 
 Primary P1-3 astrocytes were harvested from Sprague-Dawley rats 
according to established protocol[35]. Cortical astrocytes were cultured for 1 
week, shaken to remove other cell types, and then frozen in liquid nitrogen prior 
to use. Cells were thawed and cultured for 1‒2 weeks in DMEM/F12 media 
(Gibco) supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals) 
prior to treatment with 0.25% trypsin and placement onto gradient patterns. 
Astrocytes were seeded at low density of 5000-6000 cells per square centimeter 
in SATO- serum-free[36] medium. Astrocytes were cultured at 5% CO2 and 37 °C 
for the duration of the experiments. Only astrocytes that were visibly attached to 
the surfaces were imaged for subsequent analyses. 
 
4.3.2. Gradient Surface Patterning 
 Dot gradients were designed using Mathematica (Wolfram) to randomly 
place pixels as previously described[37]. The gradients were 50 µm wide and 
1000 µm long and spaced 100 µm apart by a region of 100% coverage. The 
design was then translated with L-Edit (Tanner) to create a file for an 
electromask pattern generator to expose onto a photoresist-coated mask (Telic). 
Polydimethylsiloxane (PDMS) was then cast on the mask to form stamps. To 
visualize the stamped protein gradient, aggrecan (AGG, A1960, Sigma) was 
fluorescently labeled with Alexa Fluor 594 (A-20004, Invitrogen) and eluted 
through a PD-10 Sephadex column (GE Healthcare) with phosphate buffered 
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saline (PBS) to remove unreacted fluorophore. The AGG solution was diluted to 
a concentration of 0.3 mg/mL in PBS and stored at 4 °C until use. Glass-
bottomed petri dishes (Fluorodish) were coated by adsorption with a 0.3 mg/mL 
laminin (LN, L2020, Sigma-Aldrich) solution at 4 °C overnight and then rinsed 
with double-distilled, deionized water (DDI) and dried under nitrogen prior to 
microcontact printing. Gradient stamps were adsorbed with labeled AGG solution 
for 1‒2 h at room temperature and then rinsed thrice with DDI and dried with 
nitrogen. Stamps were manually placed into conformal contact with the glass 
dish bottoms, and remained in contact for 5‒10 min prior to stamp removal. 
Gradient transfer was confirmed by imaging the fluorescent AGG. 
 
4.3.3. Time-Lapse Microscopy 
 A fully-automated Olympus IX81 inverted microscope with a 20x objective 
was used to image astrocytes in glass-bottomed dishes. A custom-machined 
aluminum holder was used to securely keep dishes in the temperature-controlled 
stage chamber. Uncovered dishes filled with DDI water were included in the 
chamber to maintain humidity. Metamorph imaging software (Molecular Devices) 
was used to control the computerized stage, filters, and CCD camera to 
automatically take images every 5 min for chosen locations. The built-in 
autofocus function of the software was used every 5 images over the imaging 
period. The captured digital images were mapped to 0.65 µm per pixel. For 
substrates with aggrecan/laminin gradients, cells were allowed to attach for 4 h 
post-seeding and then were imaged for 20 h. A substrate with a uniform laminin 
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coating was used as a control. On this substrate, the cells were imaged within 30 
min post-seeding for 24 h. Regions with cells that left the field of view, underwent 
apoptosis or were obscured by debris or intercellular contact were neglected. All 
images had background correction using a fitted 2D cubic polynomial prior to 
analysis. 
 
4.3.4. Astrocyte Morphology Quantification 
 Astrocyte outlines were measured for each cell with the aid of the ESnake 
plugin (EPFL) [38] for ImageJ (NIH). The ESnake setting for control points 
ranged from 20-50 based on cell size and morphology complexity. The Gaussian 
blur setting was adjusted from 2‒8 depending on image contrast. Cell images 
taken every 30 min were analyzed. Cell outlines were measured using ImageJ to 
quantify perimeter, area, centroid, circularity (4π*area/perimeter2), and maximum 
span or so-called Feret diameter. The cell centroid was subsequently used to 
calculate speed of migration and overall cell displacement. To analyze the 
changes in astrocyte migratory and morphological behaviors, measurements 
from the first (4 h post-seeding) and last (24 h post-seeding) observations were 
compared and reported as initial and final parameters, respectively. 
Astrocytes were divided into three categories based on the composition of 
the underlying substrate. For controls, the cells were cultured on uniform LN 
(n=15) or AGG (n=6) substrates. Astrocytes that attached with some portion of 
their cell body on the gradient area over the culture period were identified as 
gradient cells (n=8). Cells that landed on the extreme end of the gradient where 
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there were no printed patches were presented with a binary surface of a full 50 
µm wide stripe of laminin flanked by full aggrecan regions. Such cells were 
classified as binary footprint cells (n=6). The size of the binary regions varied 
slightly with each sample, but covered around the first 100 µm of the stamped 
pattern. Data were tested for statistical significance using an ANOVA with a 
Tukey-HSD post-hoc test (α=0.05). 
 
4.3.5. Assessment of Protein Preference 
 To determine how astrocytes migrate and shift their locations with respect 
to the underlying AGG/LN pattern, the fluorescence intensities of the areas 
underneath the cells with printed AGG (Alexa Fluor 594 labeled) and unlabeled 
LN patterns were compiled into histograms. Histograms that showed two distinct 
fluorescence intensity peaks; one for AGG, and the other for unlabeled LN, over 
the course of culture were used for analysis (n=7). The heights of the two 
histogram peaks were measured at 5 h intervals to track changes in substrate 
composition below individual astrocytes over time. 
 
4.4. Results 
4.4.1. Dot gradient templates successfully transferred AGG/LN  
gradients to glass substrates 
 AGG/LN dot gradients were successfully transferred to glass using 
microcontact printing methods. Observation of the AGG/LN dot gradients after 
their transfer to glass substrates revealed that small features surrounded by high 
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density of the other macromolecule were often lost compared to the design 
template (Fig. 4.1A,B). This made the printed gradient steeper than originally 
designed and also resulted in areas near each end of the gradient with uniform 
surface coverage of LN or AGG. For morphological analyses, astrocytes on the 
uniform AGG end or bounding regions that never encountered LN were grouped 
with cells cultured on uniform AGG coatings. Cells which encountered the µm-
sized patches along the gradient were classified as cells on the gradient. The 
remaining category for astrocytes included cells that interfaced with the uniform 
LN end of the gradient but also adhered to the AGG area surrounding the 
gradient (so-called binary cells) (Fig. 4.1C‒E). 
 
4.4.2. Astrocytes exhibit stellate morphology during early  
attachment on LN 
During initial attachment within 30 min of seeding on control surfaces with 
uniform LN coatings, astrocytes first extended long processes followed by 
retraction and spreading of the cell body (Fig. 4.2). Due to the latency required to 
determine astrocyte locations on gradient patterns, this early spreading behavior 
could not be observed on gradients. On uniform AGG substrates, however, cells 







4.4.3. AGG/LN dot gradients cause astrocytes to increase  
process extension length 
Astrocytes on uniform LN were more evenly amoeboid than cells on the 
other types of substrates and attained the smallest average perimeters while 
having similar cell areas. Average perimeters on LN remained unchanged 
between initial and final observations. Similarly, astrocyte footprint areas on LN 
surfaces were little changed (Fig. 4.4A,B). Astrocytes had similar sizes on 
uniform AGG vs. on gradient patterns both at initial and final observations, but 
cells on these two substrates doubled in size over the course of the experiment. 
The presence of µm-sized patches of LN in the AGG gradients caused the 
astrocytes to extend processes such that the perimeter of these cells was higher 
than on any other surface type at both the initial and final time points. In addition, 
the cells on AGG/LN gradients also had a significant 25% increase in average 
perimeter over the time of the study while maintaining a significantly less circular 
morphology compared to cells on control LN substrates (Fig. 4.4C). Astrocytes 
on AGG and binary regions had similar perimeters that were smaller than those 
for gradients but were approximately 30% larger than those on uniform LN 
controls at the final time point. Astrocytes on substrates other than LN were less 
amoeboid in general. Astrocytes processes appeared to attach to µm-sized 
patches of LN and some astrocytes at the binary footprint location extended a 
process along the 5 µm wide gap of LN between gradient patterns. 
Astrocyte spreading resulted with an average span of around 65 µm after 
initial attachment on all substrates (Fig. 4.4D). However, over the next 20 h, 
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astrocyte spans on uniform LN controls remained largely unchanged, while 
astrocytes on uniform AGG had a significant increase in span over that time. 
Astrocytes attached on gradient areas and binary footprint locations had an even 
larger increase in maximum span to an average around 150 µm, but were not 
significantly different from each other. Both pattern types (gradient and binary) 
caused astrocytes to have a span nearly double that of cells on uniform LN 
substrates. The span for an individual cell ranged from 40 µm at the smallest and 
220 µm at the largest across all samples. 
 
4.4.4. Astrocyte migration speed largely unchanged on AGG/LN substrates 
Astrocytes migrated at an average speed around 10 µm/hr on all substrate 
types (Fig. 4.4E). There were no discernible differences between astrocytes 
migration speeds at initial and final observations. Amongst all observations, 
astrocyte speed ranged from less than 1 to up to 120 µm/hr. There was also no 
significant difference in overall displacement over time of cell culture between 
different substrates, with cells being located on average 20‒35 µm away from 
their initial locations (Fig. 4.4F). Distances covered by individual astrocytes 
ranged from 1 to over 65 µm. 
 
4.4.5. Astrocytes prefer LN over AGG substrates 
 When the fluorescence intensity below each cell was presented in a form 
of a histogram (Fig. 4.5A, insert), the magnitude of the AGG peaks was found to 
decrease over culture time, while the LN peak magnitudes showed an opposite 
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trend (Fig. 4.5A). These changes in the substrate composition below the 
attached cells illustrate how the cells that encountered both AGG and LN at 
some point preferentially moved their cell bodies onto LN areas by the end of the 
culture period (Fig. 4.5B). This behavior consisted of an initial preference of 
cellular extensions toward LN followed by an eventual shift of the cell body. 
Astrocytes which initially encountered no LN patches extended process in all 
directions until LN was contacted and then preferential extension and shifting 
occurred toward LN at later time points. 
 
4.5. Discussion 
4.5.1. Astrocytes extend processes not seen on uniform,  
adhesive culture substrates 
 While alignment of astrocytes on substrates patterned with ECM 
molecules has been well documented[20,37], much less is known about how 
astrocytes interact with substrates containing composite permissive and 
inhibitory ECM molecular cues. One rationale for deciphering responses of 
astrocytes to such complex environments is to find whether there is a causal 
relationship between astrocyte morphology and migration and presented 
molecular cues. Although astrocyte morphology cannot be used a direct indicator 
of their reactivity, especially at the CNS injury site[5], it is interesting to note that 
astrocytes on standard culture substrates, such as tissue-culture polystyrene, 
polylysine or laminin, exhibit a more amoeboid morphology than what is found in 
the CNS. The observation of the initial spreading of astrocytes in a stellate 
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fashion here indicates that the presence of the uniformly adhesive substrate 
causes astrocytes to change shape over the course of several h (Fig. 4.2). 
Astrocytes presented with the µm-sized patches of AGG and LN in this study 
showed the greatest amount of process extension, as evidenced by their large 
perimeters (Fig. 4.4). Although altering morphology of astrocytes from amoeboid 
to stellate on topographically organized substrates has been show to decrease 
several markers for reactivity[22,23], it remains uncertain if the use of discretely 
patterned substrates would also influence astrocyte culture reactivity. An 
assessment of GFAP or CSPG expression of the more stellate astrocyte cultures 
observed in the present study could provide further insight for the relationship 
between morphology and reactivity. If patterns are effective at reducing astrocyte 
reactivity, they may be incorporated with other approaches that provide less 
reactive and more quiescent astrocyte cultures, such as with 3D gels and various 
alternative ECM substrates[39,40]. 
 
4.5.2. Astrocytes are capable of sampling between large distances 
The present measurements indicate that astrocytes were able to sample 
immobilized ECM molecules separated by as many as 150 µm. The greatest 
extensions for these cells were triggered by the presence of mixed molecular 
cues within the AGG/LN gradient. When presented with mixed substrate choices 
for attachment, the astrocyte may be extending processes farther as a means to 
“find” a more suitable ECM component for its final location. In the case of a less 
preferable substrate like AGG, the spans and perimeters of astrocytes were 
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higher than for LN, suggesting an attempt to find more permissive areas (Figs. 
4.3, 4.4). It is also possible that this difference in behavior is due to a subset of 
cells that were more prone to adhesion onto AGG and were also more likely to 
extend processes and avoid ameboid spreading. However, astrocytes on LN also 
initially extended process as aforementioned, and astrocytes that encountered 
both AGG and LN appeared to maintain spreading behavior on LN and not on 
AGG (Fig. 4.1E). Additionally, previous evidence indicates overall astrocyte 
adhesion is not influenced by the presence of adhesion peptides inspired by LN 
or FN compared to plain glass[41], and that substrate stiffness is a larger 
contributor to astrocyte attachment than LN availability[42]. Therefore multiple, 
mixed cues within the cellular span may augment astrocyte extension and 
sampling of substrate-bound cues compared to uniformly coated substrates (Fig. 
4.4). 
Previous studies of the effect that varying stripe widths and spacings have 
on confluent layers of astrocytes determined that the best astrocyte alignment 
occurred with 50 µm stripes of laminin, with 17 µm spacing between them[43]. 
We previously have effectively applied 15 µm stripes as well[20]. Both of these 
values are well within the range of astrocyte span found here. Similar values 
ranging from 100 to 150 µm for longest astrocyte length have been reported for 
cultures on polylysine and silk fibroin fibers[44]. Astrocytes grown on fibronectin-
coated polylactic acid fibers for 4 days were measured to extend processes 
around 50 µm on random fibers and around 200 µm on aligned fibers[45], 
indicating that restricting the available attachment points to the microfibers may 
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extend astrocyte growth even farther than patterns. Therefore, by providing 
contrasting locations for cellular attachment, astrocytes will extend processes 
farther. This response could be leveraged to increase astrocyte extension onto 
and sampling of a material by a modifying its surface to contain both permissive 
and inhibitory molecules. 
 
4.5.3. Astrocytes shift cell bodies onto LN areas, but  
displacement and speed remain low 
 Astrocytes prefer to be attached to LN areas over regions of AGG (Fig. 
4.5). In the context of glial scar formation, the upregulation of CSPG expression 
which is present at the site of CNS injury may impede astrocyte infiltration into 
the site. CSPG inhibits supportive PNS Schwann cell migration[30]. Substrates 
with regions rich in LN would promote astrocytes to preferentially attach. This 
effect, however, would be highly localized. Even though astrocytes were capable 
of moving large distances during the experiment, most cells vacillated around a 
given position where they had initially adhered. The speed of individual cells 
measured here (Fig. 4.4E) corresponded with the speed of 9 µm/hr for 
populations of astrocytes migrating through cortex in vivo and to speeds of 
mostly 10-20 µm/hr for layers of astrocytes closing a scratch wound in vitro[7,13]. 
As previously observed, astrocyte migration to the wound site is not as important 
as proliferation of the cells bordering the injury for neuroprotective roles[3]. The 
results from the present study suggest that the populating of implant surfaces 
with astrocytes will likely be analogous to formation of the glial scar, reliant on 
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astrocyte proliferation at the injury site, as opposed to recruitment of distant cells. 
However, the addition of LN patterns to such scaffolds could allow more 
astrocytes to remain attached to the scaffold and avoid their potential migration 
away from injury-induced aggrecan. 
 
4.6. Conclusions 
 Random dot gradients were created to investigate how astrocytes sample 
and migrate on surface protein patterns containing mixed adhesion cues. 
Astrocytes extend processes in a stellate fashion upon initial attachment and 
maintain extensions as evidenced by increased area and perimeter when 
presented with AGG but not with LN alone. Astrocytes do not migrate large 
distances after initial attachment, though they will shift position towards higher LN 
concentrations versus AGG. Cellular extensions were greater when astrocytes 
interfaced with discrete micrometer-scale patches of LN amongst AGG spanning 
a distance of 150 µm. These findings indicate that presenting mixed cues on 
surfaces cause astrocytes to interact with larger areas of the surface, which 
allows astrocytes to preferentially relocate. 
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Figure 4.1. Dot gradient pattern transfer and definitions of different regions. A) 
Computer-generated dot gradient template and subsequently fabricated 
polymeric stamp led to B) transferred fluorescent pattern onto glass. Scale bar = 
25 µm. C) Schematic of astrocyte characterization based on interaction with 
gradient patterns. Astrocytes in binary footprint regions did not encounter µm-
sized patterns. Cells which encountered only aggrecan were grouped in analysis 
with astrocytes cultured on uniform aggrecan controls. Representative images of 
astrocytes interacting with AGG/LN gradient and binary footprint regions are 










 Figure 4.2. Initial stellate spreading of astrocytes on uniform LN‒coated 
substrate is observed prior to final amoeboid morphology. A) Representative 
image of three astrocytes during the initial 5 h attachment period. Scale bar = 50 
µm. B) Circularity of astrocytes on control LN substrates measured over time 
indicated that a period of 5 h was required to achieve stable, round morphology. 










Figure 4.3. Astrocyte spreading on aggrecan surface. The progression of an 
astrocyte spreading on aggrecan in 0.5 h intervals. Measured outlines are shown 








Figure 4.4. Average astrocyte morphology parameters on various substrates. A) 
Area, B) perimeter, and C) circularity of cells at initial and final observations. D) 
Maximum span, E) speed, and F) overall displacement from initial attachment 
location for astrocytes on the given pattern regions and uniform surfaces. 
Statistically significant differences over time are indicated (* = p<0.05; ** = 
p<0.005) and significant differences between substrates are indicated by 









Figure 4.5. A) Astrocyte adhesion footprint shows preference for LN over time. 
Representative histogram (inset) shows two peaks corresponding to LN and 
AGG covered by an astrocyte footprint at the 14 h time point. The fraction of 
pixels of the imaged cell at peak florescent intensities for LN and AGG tracked in 
5 h intervals over time. Error bars indicate ± SEM. B) Astrocyte shifting to 





SUMMARY, DISCUSSION, AND FUTURE DIRECTIONS 
 
5.1. Summary and Discussion 
 Spinal cord injury remains a challenging clinical problem with bleak 
prospects for recovery. Towards combating this problem, nerve guidance devices 
have been extensively developed for research use. Such devices can provide 
sustained guidance and support of neurons as they attempt to regrow during the 
chronic phases of recovery (after acute and secondary inflammation have 
passed). Because reactive astrocytes will be present and interface with these 
devices after implantation, I investigated how surface protein patterns influence 
astrocyte expression of CSPG and morphology. From this work, my findings 
contribute further understanding of astrocyte behavior on substrates with protein 
patterns and provide a novel method for imparting directional information to NGC 
material surfaces. 
In Chapter 2, I employed microcontact printing of various densities of FBG 
to understand how astrocytes respond to adsorbed FBG on surfaces. The 
impetus for this study arose from two key factors: all implants are coated with 
FBG after contacting blood and soluble FBG triggers production of neuron 
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inhibitory CSPGs by astrocytes. Astrocytes specifically removed only FBG over a 
period of around 1.5 h after an initial attachment period of 4 h and did so while 
leaving other proteins behind. CSPG expression was also established as a 
quantitative tool for comparing astrocyte reactivity in this study. While much of 
produced CSPG is shed from cell surfaces, cell-associated CSPG was reduced 
when astrocytes were treated with a small molecule inhibitor of TGF-β type I 
activin receptor-like kinase receptors. No dose dependence based on FBG 
exposure was found; however, CSPG expression was demonstrated to occur at 
the FBG presenting interface. The lack of dose dependence may arise due to 
astrocytes already being in a reactive state in culture conditions, perhaps as a 
result of being on rigid substrates or the presence of albumin and other serum 
molecules. Changes in surface density of FBG may be too subtle compared to 
these other activation signals. Comparing adsorbed FBG to surface-linked FBG 
in future work would be interesting to test if the availability of FBG for uptake 
versus FBG-membrane binding events causes a change in CSPG production. 
The present results demonstrated that FBG was removed, but there was no 
obvious evidence of uptake within the astrocytes themselves. With respect to 
NGC design, these results indicates that, if astrocytes in vivo behave like these in 
vitro cells, the presence of FBG on the surface will not cause an overall increase 
in CSPG production by astrocytes, and the FBG stimulus will be removed within 
a period of h after recognition by astrocytes. This suggests that prevention of 
FBG binding may not be a determining design concern for reducing astrocyte 
reactivity. Concurrent treatment of TGF-signal inhibiting molecules would be 
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more effective at diminishing CSPG production. These studies also indicate that 
surface patterns of adsorbed proteins may be subjected to removal by astrocytes. 
Therefore, any device designed to maintain effective, continuing surface patterns 
must mitigate the removal by astrocytes. 
 Directional alignment of astrocytes has been effective at increasing 
neuronal outgrowth in vitro. Several aligning methods have been translated to 
NGC materials and devices. Directional surface protein patterns had yet to be 
tested on NGC materials, so I developed a method for transferring them to 
collagen gels. The technique relies on BS3, a bifunctional crosslinker, to facilitate 
binding of proteins to the surface of collagen. By peeling already printed patterns 
off of glass, the difficulties of directly printing a gel were circumvented. The 
objective for Chapter 3 was to verify if such patterns on collagen made any 
changes to astrocyte CSPG expression. Stripe patterns of AGG, FBG, FN and 
LN were tested. Astrocytes attached to all surfaces, and aligned to some degree 
on the patterns. Cells on FBG were the most aligned, followed by LN and FN. 
However, astrocytes on AGG had the least alignment, but they were still more 
aligned than cells on plain collagen. It is possible that the alignment efficacy was 
not only a result of the patterned stripes, but rather in response to altered binding 
of serum available or cell-secreted molecules. Likewise, astrocytes could prefer 
collagen and the effect of the patterns would be to delineate regions of available 
collagen. Such effects would also create directional patterns for astrocytes to 
align to, albeit made of different molecules than what was applied. The fact that 
astrocytes also align on striped glass with the same printed molecules suggests 
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that the stripes themselves are providing directional cues, and not the masking of 
available collagen. Likewise the limited alignment in AGG-striped collagen 
samples indicates that the periodic masking of collagen is less effective in 
causing astrocyte alignment. Astrocytes aligned on FBG and LN expressed half 
as much CSPG as cells on collagen alone. In all cases, the transferred patterns 
resisted modification and removal by astrocytes over the course of 4 days in 
culture. These results indicate that while directionality corresponds with reduced 
CSPG production in some cases, this relationship is not straightforward in all 
cases. Surprisingly, astrocytes on AGG also had around a one-third decrease in 
CSPG production, although cellular alignment was less pronounced, and FN 
stripes did not impact CSPG expression although cells were aligned by FN.  To 
improve on this work, it would be interesting to pattern the same ECM 
compounds in either random dots or a grid-like pattern on collagen to observe 
how removing directionality impacts CSPG expression. I would hypothesize that 
alignment would be reduced and that CSPG production would not be decreased 
except for patterns with AGG that, as previously mentioned, reduced CSPG 
without extreme alignment. The gels tested here were of relatively high 
concentration of collagen and are likely even stiffer after crosslinker application. 
In the future, more dilute and less rigid gels may need to be patterned using 
alternative approaches such as freeze-drying and rehydrating. Another potential 
tool would be to pattern temperature-responsive polymer surfaces while in a 
hydrophilic state and then drive the surface to become more hydrophobic with 
temperature to facilitate softer hydrogel release. 
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 In Chapter 4, my goal was to gain insight on astrocyte morphology and 
migration as they attached to patterned surfaces. Because previous astrocyte 
alignment studies relied on artificially chosen patterns, it would be helpful to 
obtain measurements of astrocytes as they interacted with surfaces to inform 
future pattern designs. Similarly, most previous studies relied on observation of 
astrocyte orientation after they had established confluent monolayers, as in 
Chapter 3. By imaging quickly after seeding, individual cell movements can be 
more readily resolved and the influence of intercellular contacts can be limited. In 
addition to uniform surfaces of AGG and LN, astrocytes were also seeded onto 
random dot gradients of AGG/LN to assess substrate preference and were 
observed in real time using time-lapse microscopy. An unanticipated finding was 
the early stellate spreading of astrocytes on uniform LN, which parallels 
morphology in the CNS but is in stark contrast with the classic amoeboid 
astrocyte appearance in long-term astrocyte cultures. This behavior is not easily 
captured without this early attachment imaging. Astrocytes appear primed to 
make multiple, separate surface attachments, but this behavior is lost in the 
presence of uniformly adhesive signals. On uniform aggrecan printed on 
adsorbed laminin, astrocytes maintained more spindly morphologies. This is 
perhaps from selective attachment to LN molecules that might be available 
through the AGG layer or from limited adhesion to AGG itself. Astrocytes on dot 
gradients of mixed AGG/LN cues maintained a greater level of process extension 
and had the largest spans (around 150 µm). This appears to be due to astrocytes 
binding to available LN from amongst the AGG as evidenced by the ends of 
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cellular processes residing on LN patches. Astrocytes on all surfaces moved at a 
rate around 10 µm/h, but they tended to migrate locally around initial adhesion 
locations as overall displacement was of about 30 µm over the course of 20 h. I 
anticipated most cells on uniform surfaces would have little motivation to migrate, 
but astrocytes with a directional gradient did not travel far either. This may be 
due to astrocytes already finding a sufficient level of LN for attachment, thus 
negating the need to find more. Inverted gradients of LN stamped on AGG were 
created as well but not quantified. Qualitative observations showed that 
astrocytes remained on the flanking regions of full LN and avoided attachment to 
the mixed AGG/LN gradient region. This further indicates that once astrocytes 
have encountered LN, they will prefer those locations over any containing AGG. 
It is also possible that the limited migration is a function of cell density, but this 
seems unlikely as scratched astrocyte layers with contact-mediated signaling 
also close cell layer gaps with leading edges moving at similar rates. Future time-
lapse studies on stripes of varying widths and spacings would provide helpful 
size references for stripe designs. Establishing pattern features that maximized 
the rate of alignment or shifting to adhesion molecules could provide a more 
rapid response from device interfacing cells. Although from gradient patterns, the 
present measurements provide feature dimensions that estimate maximum 
cellular reach and insight that mixed cues trigger increased cellular investigation 
of surface patterns. 
 The results from these chapters together indicate that, while not all 
patterns will alter astrocyte behavior, the placement of ECM molecules can 
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impact astrocyte CSPG reactivity. In designing guidance devices, there are 
multiple stimuli strategies to alter astrocyte response, including soluble and 
topographical approaches. Within the scope of  the in vitro systems used, surface 
patterned stripes of LN and FBG which align astrocyte layers are effective at 
reducing their expression of neuron inhibitory CSPG, and such patterns can be 
patterned to collagen hydrogels. While FBG leakage into the CNS may trigger 
astrcoyte reactivity, its presence on surfaces is not the determining factor for 
CSPG production in cultured sparse astrocytes as they are concurrently 
presented with rigid surfaces and serum proteins. To enhance astrocyte 
exploration of surface patterns, mixed adhesive cues may be more effective at 
triggering individual cellular extensions. Unfortunately, the present work provides 
no clear cellular mechanisms for the observed behavior. It does, however, 
provide promising perspectives towards reducing astrocyte CSPG reactivity and 
adds an engineering tool for translating the advances in surface patterning 
technologies to NGC materials. As astrocytes in the glial scar play a determinant 
role in neuronal inhibition at wound sites, attenuating their negative impacts may 
bring new treatment options for those suffering from debilitating CNS injuries. 
 
5.2. Future Directions 
5.2.1. Macrophage response to patterned materials 
Macrophages and microglia play key roles in causing inflammation leading 
to secondary injury after SCI. These cells also demonstrate neuroprotective 
behaviors. In an effort to reconcile these contrasting functions, researchers have 
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pointed to activation pathways as an important factor in altering macrophage 
behavior[1]. The M1, classically activated, and M2, alternatively activated, 
classifications have corresponded with damaging and protective influences, 
respectively. By predisposing macrophages at the wound site to express more 
beneficial roles, secondary tissue loss may be diminished which may lead to 
improved outcomes for SCI. Since the patterned materials developed in Chapter 
3 reduced the CSPG expression in astrocytes, it would be interesting to see if 
these patterns could also reduce macrophage and microglia reactivity, either 
alone or in concert with astrocytes. Similar to astrocyte studies, it has been 
demonstrated that macrophage reactivity can be modulated with topographical 
signals provided by PLA micro- and nanofibers. When compared to being 
cultured on PLA films, macrophages on fibers produced lower amounts of 
proinflammatory cytokines and had fewer occurrences of foreign body giant cells. 
There was no dependence on alignment for these fibers, but narrower diameter 
fibers led to greater reductions in macrophage reactivity[2]. Nanofibers made with 
PCL, both aligned and random, were tested with human monocytes in vitro and 
implanted subcutaneously in rats. Initial monocyte attachment was reduced on 
aligned fibers compared with random and plain PCL film controls. Both nanofiber 
constructs led to thinner fibrous capsules in vivo compared to PCL films after 4 
weeks, with random fibers having the thinnest capsules[3]. While not indicative of 
macrophage activation pathways, fewer macrophages could lead to less overall 
chemokine production at the material interface. 
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Less is known concerning macrophages and surface protein patterns. One 
study reported that macrophage migration speed increased with increasing FN 
surface concentrations, but no measurement of inflammatory markers was 
explored[4]. The stripe patterns used in this work are on the appropriate size 
scale, as microglia have been measured to span around 30‒40 um on average 
depending on their level of reactivity[5]. It would be interesting to investigate if 
restriction of macrophage morphology via surface patterns leads to diminished 
attachment or reactivity. I would anticipate that macrophages and microglia 
cultured on ECM-striped collagen gels would express lower levels of reactivity. 
This is based on the observations that macrophages on fibers which showed less 
reactivity are also restricted by their physical environment. Likewise, as there 
was an effect of pattern alignment on astrocyte reactivity, similar behavior may 
exist in macrophages, although we lack a fundamental understanding of what 
mechanisms are causing these behavioral changes 
Even if directional surface patterns do not cause direct reduction of 
macrophage and microglia reactivity, the demonstrated influence of such 
patterns on astrocytes could lead to diminished macrophage activity in cocultures 
and potentially in vivo. The reduction in astrocyte CSPG expression could also 
contribute to lower levels of macrophage inflammation. It has been shown that 
removing CSPG with systemic ChABC treatments decreases M1 macrophage 
prevalence as evidenced by CD68 expression and increases in the M2 marker 
CD206 after SCI. Importantly, IBA-1 staining indicated that overall macrophage 
numbers were similar with systemic treatment. These changes led to decreased 
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neuronal death and improved functional recovery[6]. In contrast, there is also 
evidence that CSPG from astrocytes in the early stages of injury helps microglia 
reduce production of inflammatory TNF-α and NO species[7]. As astrocyte CSPG 
is decreased with directional protein patterns, these cells may subsequently elicit 
a less inflammatory phenotype from associated macrophages. While coculture 
with astrocytes already creates less reactive microglia compared to microglia in 
monoculture[8], I would predict that microglia and macrophages cocultured with 
astrocytes aligned by surface patterns would have even further reductions in 
inflammatory markers. 
 
5.2.2. In vivo testing of patterned devices 
 The patterned collagen developed in this work could be rolled or formed 
into a basic tube (Fig. 5.1). In vivo testing in a hemisection or transection model 
would be interesting to identify potential benefits of the patterns over plain 
collagen. However, such incremental improvements are not the ultimate goal of 
SCI research as partial progress still leaves patients with the debilitating 
symptoms of paralysis, spasticity, autonomic dysfunction and/or pain. Therefore, 
the combinational synergy of multiple guidance approaches would likely lead to 
greater improvements. A schematic of some potential synergistic approaches to 
reduce CSPG reactivity and improve alignment is diagramed in Fig. 5.2. A key 
benefit to the presently developed method is that it is compatible with many 
sheet-forming processes. Pattern peel-off is not compatible with multilumen 
constructs or extruded materials, and it is incongruent with injectable materials or 
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in situ gelling. However, any process where a polymer sheet or film can 
withstand physical manipulation to be peeled should be able to lift off a protein 
pattern. Depending on its application, alternative bifuntional cross linkers, such 
as genipin, could be substituted to bind the correct reactive groups. Likewise, 
placing protein patterns onto a flexible polymer such as PDMS [9,10] could 
facilitate sheet removal steps. Patterning of random PCL nanofibers with 
polylysine has been demonstrated using microcontact printing[11], and could be 
applied to CNS studies. Rather than utilizing a uniform coating of fibers with 
some protein, as was previously done[12], aligned fibers could be printed with 
corresponding directional stripes. This duality of guidance information could 
augment the directional response. As suggested by the findings in Chapter 4, the 
presence of multiple aligned signals may improve cellular response. I would 
expect that aligned fiber materials subsequently patterned with direction ECM 
stripes would increase both directional neuronal outgrowth and astrocyte 
alignment when compared to only aligned fibers or patterns alone. 
 To infer the impact of each signal type, directional patterns could be 
placed perpendicular to topographical cues provided by fibers. Such conflicting 
designs are also informative in providing hierarchal information concerning 
directional stimuli. For example, when testing PLA fibers and electrical fields, 
DRGs were found to extend the longest outgrowth when they were concurrently 
placed on fibers and influenced by a field in the same direction. Interestingly, 
increased outgrowth was also observed on fibers perpendicular to the electric 
field. Very little outgrowth, however, was aligned with the field in contradiction to 
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the fibers. Based on these observations, topographical cues dominate electrical 
stimulus for guiding neurons[13]. Therefore, the efficacy of directional stimuli 
should be investigated to provide clues as to what factors are most important for 
directional cellular growth. I think that the directionality of fibers would likely 
override conflicting stripe patterns, but that cells presented with such 
contradicting cues will grow more slowly than those with parallel directions.  
Additionally, with the methods developed here, similar in vitro tests should be 
performed to more fully understand how surface placement of popular NGC 
molecules, such as NGF and BDNF, may work in tandem with bulk release of the 
same factors from gels. I hypothesize that directional patterns of neurotrophic 
factors would improve guided neuronal outgrowth compared to uniformly coated 
surfaces or gels solely reliant on bulk release. 
As mentioned earlier, invasive procedures to implant devices are not 
always ideal for the common contusion injuries found in human SCI, especially 
when some existing tissue has been spared. For those with complete 
transections, however, the addition of guiding structures may be beneficial. A 
recent human patient experienced partial sensory and motor recovery when 
autologous olfactory ensheathing cells were implanted into his SCI and were 
accompanied by autologous nerve grafts to provide directional support[14]. This 
is an encouraging result. No doubt the transplanted cells played an important role, 
but the question remains whether support structures are also vital for functional 
recovery. Work is also needed to understand which human patients with SCIs 
would benefit more from implanted NGCs than other treatments. 
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However, not all devices for restoring function after SCI require directional 
information at the tissue-device interface, such as stimulating electrodes. The 
demonstrated reduction in astrocyte CSPG produced by patterns could be 
beneficial in those and similar situations. The addition of astrogliosis-reducing 
patterns or coatings could lead to less inhibition of neural populations for better 
recording and stimulation. Existing electrode coatings include parylene-C which 
reduces macrophage attachment[15], and sodium alginate hydrogel which 
reduced macrophage and astrocyte reactivity around electrodes by acting as a 
cytokine sink[16]. I would expect that adding directional patterns to such gels or 
using collagen in a similar application would serve to reduce the activity of cells 
that contact the surface and maintain the diffusion sink function of the gel. 
Lastly, the developed patterned collagen from this work may also find 
application for individuals with PNS injuries where NGCs made of type I collagen 
have already been approved for use by the FDA[17]. I would anticipate that the 
addition of directional guidance molecules to collagen NGC surfaces would 
provide more rapid and efficient alignment of PNS Schwann cells which would 
also positively impact neuronal regrowth. 
 
5.2.3. Biomimetic surface patterns 
To date, most guiding patterns have been grooves, stripes or fibers. 
These artificial designs have proven effective at guiding neurons and astrocytes. 
In native tissue, however, the cellular environment is less binary. One simple 
experiment to increase pattern complexity and test synergistic effects would be to 
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stamp multiple proteins onto glass and then transfer them to collagen. For 
example, the most potent reducers of CSPG expression in Chapter 3, FBG and 
LN, could be patterned in alternating stripes to see how it impacts alignment and 
whether CSPG expression was further reduced. It would also be interesting to 
investigate more intricate patterns to see if there are improvements on neuronal 
and astrocytic growth. Kofron et al. created cell-inspired topographical patterns 
that mimicked Schwann cells and astrocytes in PDMS. They also cast PDMS 
directly onto cell layers to replicate their topography and found that such surfaces 
were effective at guiding neuronal outgrowth[18]. Unfortunately, there were no 
direct comparisons with grooves to infer whether biomimetic or artificial patterns 
are more potent. 
 A similar approach may be considered for the molecular cues presented 
by astrocytes. Work with fixed astrocytes showed that they are capable of 
reducing microglia activation without active release of soluble factors, albeit to a 
lesser extent than their live counterparts[8]. Similarly, fixed layers of aligned 
astrocytes maintain surface ligands that facilitate neurite growth and extension. 
Astrocytes were also shown to propagate alignment signals from layer to layer of 
seeded cells, thus indicating that an astrocyte aligning patterned surface may 
subsequently align both astrocytes and neurons as tissue regrows[19]. Based on 
this theory, I have developed some astrocyte mimetic patterns that were inspired 
by astrocyte expression of CSPG and FN (Fig. 5.3 A, B). Surfaces patterned with 
mixed molecules could provide potential synergy as mentioned above, and an 
alternative to periodic patterns could be random dots of cell-inspired densities 
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that would help clarify the roles of molecule concentrations (Fig. 5.3C). These FN 
and AGG patterns qualitatively appear less effective at guiding neurons (Fig 
5.3D); however, I expect they would prove more effective at orienting astrocytes. 
Such patterns are on the size scale of astrocyte extensions and astrocytes are 
less likely to migrate large distances but rather shift to more preferable pattern 
locations. Comparison of these patterns against both random dots and 
alternating stripes could reveal what types of patterns are most effective at 
aligning astrocytes and reducing reactivity. I anticipate that alignment would be 
best on stripes, but that reactivity would be further decreased on mimetic 
patterns. The random dots would likely lead to no alignment, so any decreases in 
CSPG reactivity could be attributed to the synergy of the patterned molecules.  
Such an approach would also be improved by a more exhaustive survey of 
adhesion molecules expressed on astrocyte membranes. These could be 
individually tested in artificial stripe assays to determine those with maximum 
neuronal or astrocytic guidance which would then be mapped for translation to 
stamps for patterning. 
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Figure 5.1. Stripe-patterned collagen rolled into a tube. Laminin stripes (15 µm 
wide, green) are transferred to collagen gel, which is amenable to physical 
manipulation. Astrocyte nuclei (blue) and CSPG (red) are visible around and on 










Figure 5.2. Potential benefits of directionally patterned collagen gels. Addition of 
patterns provides directional cues not present on uniformly coated surfaces. 
Multicomponent patterning and patterning in conjunction with topographical cues 
may provide increased alignment accompanied by reduced reactivity in surface 
contacting cells. Such surface properties may translate to improved outcomes for 





Figure 5.3. Astrocyte-based protein patterns. A) Confocal image of aligned 
astrocytes labeled for FN (green) and CSPG (red) expression. B) Mimetic pattern 
template made by thresholding and rastering cell image with minimum feature 
size of 3 µm. C) Random pattern template with coverage equal to mimetic design. 





CELL SUBSTRATE PATTERNING WITH GLYCOSAMINOGLYCANS TO 
STUDY THEIR BIOLOGICAL ROLES IN THE CENTRAL NERVOUS  
SYSTEM*: RANDOM DOT GRADIENT FABRICATION  
AND MICROCONTACT PRINTING 
 
A.1. Methods 
A.1 Printing Proteoglycan Gradients via Nonspeciﬁc Adsorption 
1. Generate random pixel distributions using Mathematica (Wolfram) or similar 
software. In Mathematica, the commands to create a continuous dot gradient are 
as follow:  
Cell 1 - gradientPercolation[n_, m_]:= Module[{p=0},  createRow=(p+=1/(n-1);  
h[#, Table[Floor[Random[]+p],{m}]])&  
Cell 2 - Apply[List, Flatten[Nest[createRow, Table[0,{m}], n-1], Inﬁnity, h]]]  
Show[Graphics[RasterArray[gradientPercolation[1000, 50]/. {0 ->RGBColor[1, 1, 
1],1 - RGBColor[0,0,0]}]], AspectRatio->Automatic] 
                                                          
*
 Excerpt reprinted with kind permission from Springer Science+Business Media: 
Glycosaminoglycans, Cell Substrate Patterning with Glycosaminoglycans to Study Their 




The graphics output can then be copied as a bitmap to lithography patterning 
software. This command created a 50 unit wide 1,000 unit long gradient. 
2. Create a photolithographic template…. 
3. Cast PDMS stamps … (see Note 2). 
4. Adsorb PDMS stamps with proteoglycan solutions for 30 min at room 
temperature (r.t.) (see Note 3). 
5. Rinse the stamp with water and dry with a nitrogen stream. 
6. Print the proteoglycans by placing the coated stamp in conformal contact with 
a coverslip. Allow the stamp to remain in contact with the coverslip for 1–2 min. 
Carefully remove the stamp from the coverslip. Wash the stamp with detergent 
and water and store for reuse (see Note 4). 
 7. To create a pattern made of two macromolecules there are two approaches: 
precoating the coverslip with the ﬁrst macromolecule prior to the printing of the 
second macromolecule, or coating (so-called back-ﬁlling) the coverslip with the 
second macromolecule after it was stamped with the ﬁrst macromolecule. The 
approach chosen depends on the desired combination of molecules. For 
example, coverslips coated with laminin solution (100–500 μg/mL PBS) for 1 h at 
r.t. can be rinsed with water, dried in nitrogen, and printed with aggrecan solution 
to create surfaces with laminin and aggrecan-on-laminin features. Substrates 
with laminin and laminin-on-aggrecan features can be similarly produced by 






2. For optimal PDMS removal from mask templates, it is best to remove the 
PDMS from the mask before it is fully cured and rigid. This prevents fracturing of 
the PDMS. Partial curing is accomplished by placing samples in a 100 °C oven 
for 30 min, after which the PDMS can be removed from the photoresist surface. 
The PDMS alone, without the mold, is then placed back into the oven and 
allowed to fully cure. To control for stamp thickness, the volume of PDMS mix 
can be adjusted. 
3. To facilitate the spreading of solutions and to minimize reagent use, a sterile 
coverslip can be placed on top of a small volume of solution that has been 
applied to the top of the PDMS stamp to provide full stamp coverage. If the 
hydrophobicity of the PDMS is causing difﬁculties with adsorption of inking 
proteoglycans, a brief plasma treatment [17], either in oxygen or corona 
discharge in air, immediately before adsorption can render the surface 
hydrophilic, although the surface tends to revert to being hydrophobic over time. 
4. After use, PDMS stamps should be sonicated in a mild detergent and rinsed 
with water. The stamps can be stored submerged in water or be dried and sealed 




17. Anderson JR, Chiu DT, Wu H et al (2000) Fabrication of microﬂuidic systems 
in poly(dimethylsiloxane). Electrophoresis 21:27–40 
